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1.

ABSTRACT

Bioresponsive hydrogels are emerging with technological significance in targeted
drug delivery, biosensors and regenerative medicine.

The design challenge is to

effectively link the conferred biospecificity with an engineered response tailored to the
needs of a particular application. Moreover, the fundamental phenomena governing the
response must support an appropriate dynamic range, limit of detection and the potential
for feedback control. The design of these systems is inherently complicated due to the
high interdependency of the governing phenomena that guide sensing, transduction and
actuation of the hydrogel. The objective of the dissertation is to review the current state
of bioresponsive hydrogel technology and introduce a method of extending the
technology through integrated control loops; explore fundamental phenomena which
affect ion transport within biomimetic hydrogels; and investigate, via in silico studies,
the fundamental design parameters for the implementation of a feedback control loop
within a bioresponsive hydrogel.
In one study, effects of valence number, temperature and polymer swelling on
release profiles of monovalent potassium and divalent calcium ions elucidates
mechanistic characteristics of polymer interactions with charged species.

For

comparison, ions were loaded during hydrogel formulation or loaded by partitioning
following construct synthesis. Using the Korsmeyer-Peppas release model, the
diffusional exponents were found to be Fickian for pre- and post-loaded potassium ions
while preloaded calcium ions followed an anomalous behavior and postloaded calcium
ii

ions followed Case II behavior. Results indicate divalent cations interact through cationpolyelectrolyte anion complexation while monovalent ions do not interact with the
polymer. Temperature dependence of potassium ion release was shown to follow an
Arrhenius relation and calcium ion release was temperature independent.
In another study, data generated from the previous Chymotrypsin system is used
to build and validate a finite element model. The model provides insight into key
engineering parameters for the design of an enzymatically actuated, feedback controlled
release. A drug delivery platform comprising a biocompatible, bioresponsive hydrogel
and possessing a covalently tethered peptide-inhibitor conjugate was engineered to
achieve stasis, via a closed control loop, of the external biochemical activity of the
actuating enzyme. The FEM model was used to investigate the release of a competitive
protease inhibitor, MAG283, via cleavage of Acetyl-Pro-Leu-Gly|Leu-MAG-283 by
MMP-9 in order to achieve targeted homeostasis of MMP-9 activity, a goal for the
treatment of chronic wound pathophysiology. It was found the key engineering
parameters for the delivery device are the radii of the hydrogel microspheres and the
concentration of the peptide-inhibitor conjugate loaded into the hydrogel.
Homeostatic drug delivery, where the focus turns away from the drug release rate
and turns towards achieving targeted control of biochemical activity within a biochemical
pathway, is an emerging approach in drug delivery methodologies for which the potential
has not yet been fully realized. By understanding mechanistic phenomena and key
engineering parameters for design, advancements in bioresponsive hydrogels will
continue to produce novel technologies in biomedical applications.
iii
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CHAPTER ONE
1.
1.1.

BIORESPONSIVE HYDROGELS

Introduction
Biologically responsive (bioresponsive) hydrogels are stimuli responsive

hydrogels wherein the response of the hydrogel is triggered by recognition of a biological
agent by an immobilized biorecognition species. Biological agents may be biomolecules
like glucose[8], large macromolecules like chymotrypsin
vascular endothelial cells

[10, 11]

.

[9]

, or even whole cells, such as

Biorecognition species can be native or synthetic

biomacromolecules such as enzymes, antibodies, nucleic acids
such as metabolites or peptides

[16, 17]

[12-15]

, or small molecules

. The triggers may result in responses which

include, among others: swelling or collapsing, degradation, mechanical deformation,
optical density changes, or electrokinetic variations

[18]

. The response may be binary, as

in presence or absence of the biological agent at a particular threshold limit, or it may be
scalable with the chemical potential or activity of the biological agent

[19-21]

.

Bioresponsive hydrogels link hydrogel responses to innate specificity of bio-recognition
reactions which enables them to elicit a response upon meeting specific criteria

[22]

. This

creates a “smart” material because it is able to sense surrounding biological agents and
can remain in stasis or become dynamic depending on changes in the surrounding
environment

[23,

24]

. Bioresponsive hydrogels may share features with, but are

distinguished from, biomimetic hydrogels that contain elements of chemistry, structure,
architecture, morphology and materials properties intended to mimic local biological

1

properties and from bioactive hydrogels that contain elements intended to participate
within known biochemical pathways.
The engineering of bioresponsive hydrogels is often difficult because:

i)

molecular and architectural design must be properly specified and fabricated, ii) there are
biologically imposed constraints in conditions of materials processing, and iii) there are
complex interactions between the hydrogel matrix, the conferring bioactive species, the
targeted biological agent, and the solvent (usually water) during performance. Successful
design requires multiple length scale theoretical and experimental modeling to control
kinetic, thermodynamic, and transport phenomena [25-28]. Additionally, immobilization of
the biorecognition species must be achieved while maintaining its bioactivity.
The utility of bioresponsive hydrogels is vividly apparent in their applications.
These hydrogels have been used in tissue engineering [29, 30], in mediated drug delivery [3133]

, and biosensing applications [34-37]. In tissue engineering, bioresponsive hydrogels have

been used as biomimetic matrices, which promote cellular proliferation but also
biodegrade over time. In drug delivery, it is commonly desired to deliver a drug in
specified doses to a specific site, organ, or biological system

[38-40]

.

Bioresponsive

hydrogels are capable of location specific delivery because they are able to release the
therapeutic drug payload when they are triggered by biologically derived, site-specific
stimuli

[41]

. In sensor applications, bioresponsive hydrogels can produce a measurable

response when a specific analyte of biological origin is present [42].
Below, fundamental design and applications of bioresponsive hydrogels will be
discussed to highlight their capabilities. In this discussion, considerations in the design
2

of bioresponsive hydrogels will be given, which focus on information flow control,
incorporation of control loops into the material and fundamental phenomena in the design
of bioresponsive hydrogels.

Subsequently, previously engineered systems will be

discussed to demonstrate approaches and methods of designing bioresponsive hydrogels
utilizing various physical phenomena for sensing, transduction and the response.
1.2.

Design Considerations of Bioresponsive Hydrogels

1.2.1. Biological Event, Transduction-Signal Creation and Response
Figure 1-1 illustrates the overarching platform technology in the form of a process
flow diagram that outlines the three main steps of the general mechanism by which a
biological agent creates a response within a hydrogel. (1) A biological agent comes into
contact with the hydrogel. It is “sensed” by a biorecognition species within the hydrogel
through binding or catalysis. (2) Transduction occurs by perturbing the thermodynamic
equilibrium of the bioresponsive hydrogel through chemical potential created by the
recognition reaction.

(3)

A response occurs as the hydrogel system restores

thermodynamic equilibrium based on the new conditions. To exemplify this process
consider the case where a substrate (bioactive agent) diffuses into a bioresponsive
hydrogel with an immobilized enzyme (biorecognition species). The enzyme will first
complex and begin to catalyze the substrate (biological event).

The concentration, or

chemical potential, of substrate present within the hydrogel will determine the rate of
substrate catalysis (transduction).

Product will be continuously formed until the

thermodynamic equilibrium is reestablished (response).

3

An additional step, Step 4, an integrated control loop, is also illustrated in Figure
1-1 and discussed in the subsequent section. Considering the previous example, this could
occur when appearance of the product induces a collapse of the hydrogel which reduces
the diffusivity of the substrate into the hydrogel; in which case the chemical potential of
the substrate will have a self-limiting effect (feedback) on the response of the hydrogel.

Figure 1-1: Information flow scheme of bioresponsive hydrogels.
1.2.2. Next Generation Bioresponsive Hydrogels – Closing the Loop
The historical development of bioresponsive hydrogels has proceeded with
incremental advances to a broadening base of scientific knowledge.

Responsive

hydrogels began with polymers which were able to sense and respond to environmental
stimuli such as temperature and pH (Generation 1).

Further development led to

bioresponsive hydrogels which sense biological agents pertinent to specific biological
systems, pathways, or processes (Generation 2).
4

Development and optimization of

bioresponsive hydrogels has improved and forged new applications in a variety of fields;
however, to continue their advancement a fundamental design concept is required in the
information flow scheme. That is, the inclusion of closed control loops integrated into the
hydrogel such that the hydrogel material and the surrounding environment operate as a
cohesive system (Generation 3). Gen3 hydrogels’ responses effect and are affected by
upstream or downstream processes in a manner which potentiates or attenuates biological
activity accordingly. These materials will function as a synthetic metabolic pathway
capable of therapeutically administering drugs personalized to a patient’s biological
activity [43].
Conceptualization of an integrated feedback loop has existed for some time[44],
and proposed platforms based on pH sensitivity or binding affinity have been
demonstrated experimentally [8, 16, 45]. Balazs and Aizenberg illustrate this capability with
regard to thermo- and mechano-responsive polymer control systems

[46]

. Others have

demonstrated in silico systems which provide methods for parameter optimization[47, 48].
In all, these examples have been building towards full biomolecular integration; however,
in vitro and in vivo demonstration of full integration is only beginning to be developed
[49]

. This is exemplified in the glucose responsive hydrogels of Guiseppi-Elie et al

[8]

,

where insulin was released based on exposure to glucose emulating the natural endocrine
response; however, because the necessary metabolic pathways needed to affect the
solution concentration of glucose were not present, the system’s response (a change in the
rate of release of insulin) was not informed by a change in the concentration of glucose.

5

Figure 1-2: Current blood glucose monitoring system, as outlined by the FDA, involving
a glucose sensor, controller, and insulin pump can be reduced to a single polymeric
material, a glucose sensitive hydrogel [1].
Other potential applications for Gen3 hydrogels exist in cancer

[50, 51]

, opiate based

therapeutics[52], HIV therapy [53, 54], and anesthesia [55].
The integration of control loops into bioresponsive hydrogels offers two distinct
advantages over existing technologies: (1) reduction of multiple discrete components
required for control loops into one material and (2) tighter control over therapeutic
delivery enabling therapies which were not previously achievable. The components of a
typical control scheme are a sensor-transducer (glucose sensor), an electrical controller
(computer) and an actuation-response (insulin pump) device which is exemplified in
Figure 1-2.

Gen3 hydrogels intrinsically perform the operation of all three devices
6

reducing the system into one material which can be synthesized at the nanoscale. The
first in vivo demonstration of a Gen3 hydrogel is given by, Gordijo (2011), where bloodglucose concentrations are controlled by a glucose-responsive, insulin-releasing
hydrogel[49]. Others have developed in vitro closed loop systems for chemomechanical
pumps

[56]

, chemostatis

[57, 58]

and chemomechanical microvalves[59,

60]

. While these

systems are based on phase transition behavior, there are unexplored opportunities to
couple such systems with bioresponsive hydrogels for novel applications. The other
advantage of Gen3 hydrogels is the extension and improvement of current therapeutic
delivery devices.

Where current administration of therapeutic molecules may involve

time intensive assaying of samples, dosing amounts inconsequential of metabolic activity
or systemic delivery of molecules reducing efficiency and efficacy, Gen3 hydrogels sense
local metabolic activity and administer therapies spatiotemporally in biologically relevant
doses.
1.2.3. Control Theory in Bioresponsive Hydrogels
Control theory in Gen3 hydrogels is applied to two processes, the intrinsic
metabolic process and the engineered sense and response of the hydrogel. Control theory
in metabolic processes is a continually growing field with developed models for natural
metabolic feedback and feedforward control loops [61, 62]. Control theories are being used
to understand processes such as natural, closed-loop blood glucose control

[63]

,

neurological disease [64], and regulation in cellular networks [65]. Conversely, the control
theory around Gen3 hydrogels has not been extensively developed. Current control loops
involve a controller device, the controller in Figure 1-2, which can be programed with the
7

appropriate control schemes, PID or SPID being most common in biological applications
[66]

. The “programming” of Gen3 hydrogels is fundamentally different as tuning of

physical parameters, such as diffusion constants, loading concentrations or swelling
properties, will be used to effect time constants, τi, and gains, Ki .
Two classical control loops, feedback and feedforward, are illustrated in Figure
1-3A. Additionally, the associated block diagram with transfer functions for a feedback
control loop is shown in Figure 1-3B. In this diagram, the metabolic processes under
control, such as a single or multiple enzymatically catalyzed reactions, are shown as one
transfer function,

. The transfer functions for transport of the biological moiety

which will be sensed by the hydrogel,
transduction of the sensing signal,

, the sensing event,

, and the response,

, the

, are shown as separate

transfer functions. The setpoint, βsp, is the biological activity of some moiety, such as a
local enzyme activity or concentration of an analyte, and is selected based on the desired
outcome of the engineered system. The error signal, E, is the difference between the
current activity of the bio-moiety and the setpoint, is zero when the current activity
equals the desired activity, and deviates away from zero when disturbances are
introduced into the system. A notable difference between classic control systems and
control loops integrated into hydrogels is that classical control systems have discretely
identifiable components, such as sensors, transducers and actuators, while hydrogels
integrate all functionality of the separate components into a single material; however, like
classic control systems it is key to appropriately tune the hydrogel, through physical
parameters such as reaction rates or effective diffusivities, to achieve the desired control.
8

Figure 1-3: (A) Conceptualization of feedback and feedforward control loops using
bioresponsive hydrogels. (B) Block diagram with transfer functions for positive or
negative feedback control loop.

9

An example of molecularly engineered feedback control loops was demonstrated
by Gu

[67]

, wherein, glucose-actuated, insulin-releasing hydrogels exhibited closed loop

control of blood glucose concentration in a type 1 diabetic mouse model. Nanocapsules
containing glucose oxidase and insulin were incorporated into chitosan hydrogel
microspheres and injected into the subcutaneous dorsum of the mouse. Glucose oxidase,
acting as a combined sensor-transducer, catalyzed local glucose into gluconic acid
consequently decreasing the local pH. The protonatable chitosan, acting as a combined
transducer-actuator, swelled in response to the altered pH and thereby increased the
effective diffusivity of the entrapped insulin. Released insulin, acting through insulin
receptors on cells, increases consumption of glucose thereby reducing the blood glucose
to the set point, normal blood glucose level. The system was capable of responding to
disturbances in glucose levels. Development of transfer functions for each process;
sensing, transduction and response, will depend on the molecular phenomena involved in
each step.

In sensing, diffusion-reaction phenomena will need to be appropriately

modeled and subsequent transfer function developed [68, 69]. For transduction, the transfer
function will depend on how information is processed through temporal chemical
potentials. A transduction transfer function can be exemplified by the Laplace
transformation of Equation (1)

[70]

, a simple model for pH dependent polymer swelling,

into Equation (2).
( )

( )

( )

(1)

( )
( )

(2)
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Where Q(t) and pH(t) are the time dependent swelling ratio and pH of the hydrogel,
respectively; Q’ and pH(t)’ indicate deviation variables of the respective parameters; and
is the transduction transfer function for changes in swelling ratio from changes in
pH. Transfer functions of the response will be determined by underlying phenomena
such as diffusion-reaction, mechanical, optical or electrochemical. For further reading of
control theory in biological applications, the reader is directed elsewhere [61, 71].
1.2.4. Polymer Characteristics and Effects in Bioresponsive Hydrogels
In bioresponsive hydrogels, interactions between biological species and moieties
or architecture within the polymer play a key role in the materials’ ability to sense and
respond to changes in its environment. For the polymer, key characteristics which will
affect performance include, but are not limited to, network morphology, biocompatibility
and environmental responsiveness.
Network morphology describes the orientation of polymer chains and void spaces.
It directly affects transport and mechanical properties altering movement of biological
agents within and affecting cellular response to the hydrogel

[72-74]

. Polymer swelling

theory, originally developed by Flory and Huggins(1943) and extended by others, enables
the determination of quantitative parameters describing structural characteristics of
swollen hydrogels which includes: degree of hydration (DoH), swelling factor (Q), void
fraction (ε), tortuosity (τ), the average molecular weight between crosslinks ( ̅ ), crosslinked density (

⁄

) and the pore or mesh size ( ). Void fraction is a measurement of

the space occupied by the pores within hydrogel. Tortuosity is a ratio of the transport path
11

taken through the pores to the measured thickness of the hydrogel. Degree of hydration,
expressed as a percentage, DoH, is the ratio of the amount of water taken up by the
hydrogel to the weight of the hydrated hydrogel. The swelling factor, Q, represents the
ratio of the volume of the swollen hydrogel, Vs, and the polymer volume, Vp. Crosslinked density, (

⁄

), is the molar concentration of crosslinks. The parameter ̅

represents the average molecular weight of polymer chains between neighboring crosslinks or junctions. The network mesh or pore size, ξ, is determined by the average
distance between cross-linked points in the gel and thereby describes the degree of
hydrogel porosity. A schematic illustration of ̅ and ξ in a two-dimensional rendering
of a water-swollen hydrogel is shown in Figure 1-4.

Figure 1-4: Schematically illustrates the concept of swelling of a hydrogel by the
imbibition of water.
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Table 1-1: Table of equations for parameters which fully characterize the network
morphology and polymer structure of a hydrogel.
Parameter

Equation

Measurement

REF

DoH

(3)

Weight

[9]

Q

(4)

Volume

[75]

(5)

Weight, Volume

[9]

(6)

Diffusivity,
Effective
Diffusivity,
Weight, Volume,
Partitioning

(7)

Volume, Tensile,
DLS or HPLC

(8)

Volume, Tensile

[79]

(9)

Volume, Tensile

[79]

(

εi

)

τ

̅

̅
[ ]

[ ]

(
(
(

⁄

̅
)(
̅

)(

)

)
⁄

)

⁄

[9]

[76-78]

⁄

ξ

[

]

Where i is the state of the polymer (s = swollen, d = dehydrated, r = relaxed), M is the
weight of the hydrogel, ρ is density, Deff is the effective diffusivity of a moiety within the
hydrogel, KP is the partitioning coefficient, D0 is the diffusivity of a moiety in the
hydrating buffer, τs is the stress at a particular strain, R is the ideal gas constant, T is
temperature, ̅ is the molecular weight of the polymer chains prepared under identical
conditions without cross-linker, α is the elongation ratio,
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and

are the polymer

volume fractions in the swollen and relaxed state, respectively, αs is the ratio of deformed
length over original length under compression and NA is Avogadro’s number.
Combing polymer swelling theory with transport models based on hydrogel
morphology, Table 1-2, enables powerful predictive capabilities in bioresponsive
hydrogels. For more robust treatment of the polymer swelling theory and its effects on
transport phenomena, the reader is directed Peppas et al. [76, 82].
Table 1-2: Diffusive transport theories as they apply to hydrogel morphologies.
Theory

Hydrogel Morphology

Free Volume

Porous

Free Volume

Nonporous, Highly Swollen

Hydrodynamic

Obstruction

Micro-Porous

Governing Equation

Ref

( )

(

(

̅
̅
) (

Porous

̅
)
̅

(

)

)

(10)

[76, 92, 93]

(11)

[76, 93, 94]

(12)

[76, 93, 95]

(13)

[76, 93, 96]

Where Dip is the diffusion coefficient of species i in the polymer matrix; Db is the
diffusion coefficient of the solute through the bulk; Diw is the diffusion coefficient of
species i in the solvent; λ* is the diffusional jump length of the solute; υ is the jump
frequency; Mc is the average molecular weight between crosslinks; Mn is the average
molecular weight of the polymer without crosslinks; Mc* is the critical molecular weight
between crosslinks; Q is the degree of swelling; λ is the ratio of the solute radius to the
average pore radius or mesh size; α, β, and γ are constant dependent on the system; Kp is
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the partitioning coefficient; and Kr is the fractional reduction in diffusivity as the solute
diameter approaches the pore diameter.
Performance of bioresponsive hydrogels can be negatively affected if the polymer
is not biocompatible as protein fouling or the inflammatory response can inhibit transport
of biological agents, by degradation of the biological agents or through fibrous
encapsulation, required for triggering or compromise the immobilized biorecognition
species.

Material’s Science has sought to passively reduce fouling by reducing

interfacial energy between biological fluids and the polymer, promoting entropic
repulsion to inhibit proteins from approaching surfaces, and increasing the strength of
water-polymer interactions above polymer-protein interactions

[83]

.

Conversely,

bioresponsive hydrogels can actively reduce protein fouling by surface immobilization of
the thrombin inhibitor, heparin

[84]

, degrading fibrin networks by activation of

plasminogen [85, 86], controlled release of modified heparin [87] or self-cleaning via thermal
cycling

[88]

.

Additionally, the reduction of inflammatory response has also been

demonstrated in bioresponsive hydrogels through immobilization of MMP inhibitors

[89]

,

cytokine-inhibitory peptides [90], or cell mediated release of dexamethasone [91].
Polymer characteristics can be heavily dependent on environmental parameters.
Flory-Rehner theory was originally developed to describe the environmental effects on
entropic polymer relaxation (rubber elasticity theory)[80] and free energy dependent
swelling (equilibrium solvation theory)[97]. Extensions of the theories have included
LCST prediction

[98, 99]

and pH dependence.

pH, more often than temperature in

bioresponsive hydrogels, is used to effect polymer solvation which directly can change ε,
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τ, E and . Swelling relations for cationic and anionic polymers prepared in the presence
of solvent are given in Equations (14) and (15), respectively.
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Where I is ionic strength and Ka and Kb are the acid and base dissociation constants,
respectively

[76]

. Performance of biorecognition species immobilized in bioresponsive

hydrogels can affect

[100, 101]

or be affected

environmentally responsive polymers.

[102]

by the dynamic solvation of

In this manner, the ability to affect polymer

characteristics is leveraged as a transduction mechanism in bioresponsive hydrogels.
1.2.5. Reaction-Diffusion Considerations in Bioresponsive Hydrogels
In bioresponsive polymers chemical reactions and diffusive transport are
inherently coupled as enzyme catalyzed or ligand binding reactions are the first step of
the process flow. Often, complexities arising from coupled reaction-diffusion phenomena
are eliminated by assuming a rate limiting mechanism, such as diffusive transport,
chemical reaction kinetics, or polymer swelling, is governing the response rate

[103]

. In

enzyme catalyzed systems, the rate limiting step can be determined by the Thiele
modulus, Equation (16), a ratio of the reaction and transport rates which predicts φ<1 for
reaction limited and φ>1 for transport limited cases[104, 105].
16

[

]

(16)

Where R is the characteristic length, α is a constant dictated by the geometry (α = 1, 2, or
3 for slabs, cylinders, or spheres, respectively), φ is the Thiele modulus, Deff is the
effective diffusivity constant, and KM and Vmax are the enzyme kinetic constants [106]. The
Thiele modulus provides a method for optimization of enzyme catalyzed systems

[9]

.

Additionally, it has been developed for other cell [107] and antibody[108] based systems, but
these mathematical relations have yet to be utilized in bioresponsive hydrogels. Other
measures for competing rate phenomena include the Damkohler number (Da), Peclet
number (Pe) and the mass transfer Biot number (Bi) [109], Equations (17) - (19).
(17)
(18)
(19)
While assuming a rate limiting step can be used to obtain a reasonable fit to
experimental data, it is only an approximation and may eliminate opportunity for
versatility often demonstrated by nature

[110]

. Conversely, reaction-diffusion phenomena

in bioresponsive hydrogels can be resolved through explicit derivations, which may
require simplifications for mathematical solutions, or by finite-element modeling, which
can handle multiphysics modeling with the increase in computational power over recent
decades. Understanding and controlling reaction-diffusion phenomena in bioresponsive
hydrogels has resulted in novel applications such as increasing throughput for protein
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hydrogel-based microchips

[111]

, determination of protein-ligand dissociation constants in

the picomolar range [112] and insights into redox polymer based biofuel cells [113].
1.2.6. Conferring Biospecificity to Hydrogels
The design of bioresponsive hydrogels seeks to unite the conferred capacity for
biorecognition of a bioreceptor with the capacity for a tailored response using unique
macromolecular structures and architectures of the hydrogels. Biorecognition may be
conferred through the immobilization

[114]

(physical entrapment, polyelectrolyte complex

formation, covalent bonding, or adsorption) of biologically active moieties such as
peptides, nucleic acids, enzymes, antibodies, antibody fragments, sub-cellular fragments,
or whole cells. Most commonly, these are molecular entities such as peptides and nucleic
acids which may be pendant to the hydrogel network backbone or may serve as covalent
or virtual crosslinks. Hennink and Nostrum have reviewed cross linking methodologies in
hydrogels [115].
A widely used application of pendant peptide sequences is the attachment of the
peptide Arg-Gly-Asp (RGD) which promotes receptor mediated cellular attachment via
integrins [116]. Additionally, peptide sequences can be immobilized within the hydrogel to
create protease degradable hydrogels [117]. A common example is the immobilization of a
bioactive peptide that may be cleaved by an external proteolytic enzyme thus releasing a
drug that diffuses out of the hydrogel. The early patents of Kopeček et al. [118, 119] describe
the synthesis of polymers of N-2-(hydroxypropyl)methacrylamide (HPMA) and its
copolymerization with reactive monomer for the subsequent covalent immobilization of
bioactive entities such as enzymes, hormones and drugs. Similarly, the patent filing
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[120]

and publications of Langer

[120, 121]

illustrates this enzyme mediated schema with a

dextran-peptide-methotrexate conjugate cleavable by matrix metalloproteinases, MMP-2
and MMP-9, for tumor-targeted delivery of the chemotherapeutic agent. These early
patents teach and the publications clearly demonstrated the principle of enzyme mediated
release. The subsequent work of Kopeček also illustrates this scheme within HPMA
copolymerized with the cleavable tetrapeptide conjugate (Gly-Phe-Leu-Gly) of
doxorubicin (DOX) directed at cancer therapy

[122]

.

The tetrapeptide-conjugated,

doxorubicin (DOX) containing degradable hexapeptide diacrylate [MA-(GFLG)-Orn(GLFG)-MA] crosslinked HPMA hydrogel was used to study how the molecular weight
(22–130 kDa) of the peptide would affect treatment of OVCAR-3 human ovarian
xenografts in nude mice

[123]

. The results showed clearly the need for an appropriate

molecular weight to promote long circulating times in circulating drug delivery and
tumor targeting systems that exploit the enhanced permeability and retention (EPR) effect
for the treatment of solid tumors

[124]

. Covalent attachment as a strategy may exploit

reactive functional groups, such as primary amines, acids and thiols of pendant moieties
of the hydrogel backbone of the swollen hydrogel

[119, 125]

or may be synthesized as

polymerizable monomer or pre-polymers that are directly polymerized into the network
[24]

. This type of enzyme mediated delivery system is now well known and is the subject

of further patents [126] and considerable predictive refinement [125].
A special case is the targeting of MMP activity. MMPs are of particular interest as
they are over expressed in both chronic wounds (pressure ulcers, diabetic ulcers, etc.) and
in invasive solid tumors (e.g. gliblastoma multiforme)
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[127]

. Both environments

demonstrate deviations from homeostasis in the construction/destruction of the
extracellular matrix

[128]

. The patent application of Trotter and Slloock entitled “enzyme

sensitive therapeutic wound dressing”

[129]

illustrates the concept of enzyme mediated

release in relation to MMP activity. Recently, Gemeinhart et al. have expanded upon this
theme to demonstrate release of a fluorophore via the cleavage of a MMP-2 specific
peptide sequence that was immobilized within a cross-linked poly(ethylene glycol)
diacrylate

hydrogel

[130]

.

Using

the

photoinitiated

mixed-mode

thiol-acrylate

polymerization method of Anseth [131, 132], they achieved insertion of the thiol-terminated,
MMP-2 specific, Rhodamine conjugated peptide sequences into the hydrogel backbone.
Gemeinhart et al.

[133]

investigated the influence of molecular weight, conjugate loading

and hydrogel mesh size on the MMP-2 mediated release of the fluorophore. A critical
mesh size, commensurate with the hydrodynamic radius of MMP-2 was identified above
which MMP-2 entered the hydrogel.
The foregoing work is now being extended to the use of biologically responsive
“smart” hydrogels, wherein, negative feedback control is achieved by enzyme mediated
release of a factor which regulates the activity of a biological species outside the
hydrogel, subsequently reducing the release rate of the factor. Living systems possess
molecular mechanisms which allow them to maintain optimized physiological conditions,
despite variations and disturbances to their environment. Homeostasis is thus a selfadjusting mechanism involving negative feedback control. The design, synthesis and
fabrication of biologically responsive hydrogels to achieve homeostasis in external
biological activity is a novel, and until now, an unexplored concept.
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A reverse of the foregoing, the immobilization of an enzyme within the hydrogel,
is likewise feasible. Such configurations are commonplace in the construction of enzyme
amperometric biosensors

[134]

. In this case, the diffusible substrate, enters the hydrogel,

reacts and generates a product that causes a change within the hydrogel. In the exampled
work of Guiseppi-Elie et al.

[8]

, glucose oxidase was co-immobilized by physical

entrapment along with insulin within a pH responsive p(HEMA-co-DMAEMA)
hydrogel. The mesh size was designed, in the un-protonated state, to permit ready
diffusion of glucose into the hydrogel with little diffusion of insulin out. The catalytic
action of GOx acting upon glucose results in the generation of gluconic acid leading to
protonation of the 3° amine of DMAEMA and further swelling of the hydrogel. The
expanded hydrogel, through an enhanced diffusion coefficient, then released insulin.
The final two immobilization techniques for bioresponsive hydrogels are binding
and adsorption. In binding, one member of the binding pair, such as biotin or protein-G,
is first covalently immobilized and serves to immobilize the recognition molecule such as
strepavidin. These species serve as cross-linking agents and by competitive binding can
swell or collapse the hydrogel

[16, 135]

. Adsorption immobilization of biomacromolecules

has been thoroughly investigated, and it has been found that important factors controlling
adsorption and desorption are hydrophilic/hydrophobic and electrostatic interactions
136]

[128,

. Recently, the adsorption immobilization of enzymes on silicon nanoparticles and the

subsequent incorporation into hydrogels has been demonstrated.

Improved activity,

reduced enzyme leaching and improved mechanical strength were shown [137].
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1.3.

Transduction Mechanisms and Response Types

1.3.1. Swelling and Collapse
Bioresponsive hydrogels may utilize swelling or collapse of the polymer network
as a signal-transduction mechanism. The process of swelling and collapse occurs through
ion actuation or virtual crosslinks. The two transduction mechanisms are discussed here
and applications in bioresponsive hydrogel are given.
Transduction in bioresponsive polymers occurs through the networks of highly
hydrophilic monomer containing moieties such as ethers, thiols or hydroxyls and
ionizable groups such as carboxyls and amines. The latter groups have individual pKa
values which, depending on monomer composition and dissociation strength, will
produce a net charge on the hydrogel. Net charge neutrality is maintained by balancing
the hydrogel charge with counterions drawn from the solution. Increasing or decreasing
concentration of ions leads to an electroosmotic pressure as well as a space charge layer
that extends into the diffusion layer in solution. A hydrogel in solution will swell or
collapse to reach an equilibrium point where the osmotic pressure force, which drives
water into the hydrogel, is balanced by the mechanical retractile forces of the chemical
bonds holding the matrix together. This balancing of osmotic and mechanical forces in a
hydrogel matrix is similar to the deformation of a spring to which a force is applied
140]

[138-

. This process has been modeled using a FEM approaches which relates transport,
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Equation (20), electrostatics, Equation (21), and chemo-mechanical deformation,
Equations (22) ‒ (25)[141, 142].
(

)

(

)
(
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)

(20)
(21)

( ) )

(22)

)

(23)

∑(

)

(24)

(25)
Where C as concentration of species i; Deff is the effective diffusivity; z is the ion valence;
um is the ion mobility; F is Faraday’s constant; V is potential; R is a reaction term; ε0 and
εr are the vacuum and relative permittivity’s of the ion, respectively; σ is the stress tensor;
E is the elasticity tensor; u is the geometric strain; επ is the swelling strain; k is the
swelling coefficient; π and π0 are the osmotic and initial differential osmotic pressures,
respectively; R is the ideal gas constant; T is temperature; Cα and Cαref are the
concentrations and reference concentration at the gel-solution boundary, respectively; f is
the mechanical damping parameter; ρ is the mass density; and b is the volume forces.
Equations (20) ‒ (25) have been combined and implemented in FEM models to predict
swelling and collapse

[143, 144]

; however, extensions of FEM models into bioresponsive

hydrogels, where the swelling or collapse is triggered by a biological agent, are largely
undeveloped.
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To utilize ionic transduction in bioresponsive hydrogels the reaction between the
biorecognition species and the biological agent must produce or transport ionically active
species to the interstitial spaces of the hydrogel. The ionic species alters the equilibrium
in the system and induces the cascade of chemical, electrical, and mechanical phenomena
resulting in swelling or collapse. This has been exemplified by oxidoreductase

[145, 146]

and hydrolase [24, 147] enzyme systems and endosomolytic release systems [148, 149]. Novel

Figure 1-5: Reaction scheme, equivalent electronic circuit, and true table for the AND
gate for multisignal-response hydrogels as AND/OR logic gates [5].
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applications for these types of bioresponsive hydrogels include fully integrated feedback
control[49] and multisignal-response hydrogels as AND/OR logic gates [5], Figure 1-5.
Alternatively, reversible crosslinks can be used to swell or collapse a hydrogel in
response to a biological agent. Crosslinking in hydrogels effects hydration by increasing
or decreasing the mechanical retractile force which is counter-balanced by osmotic
pressure, thus causing swelling or collapse of the polymer network.

The effective

crosslink density νe, can be related to swelling ratio by Equations (26) ‒ (28) [150].
(

)

(26)
(27)
(28)

Where τ is the compressive strength, G is the compressive modulus, R is the gas constant,
T is temperature, α is the ratio of hydrogel thickness before and after swelling, V0 and V2
are the volume fraction of the polymer network during formation and after hydration,
respectively, and ρg and ρs are the densities of the dried and solvated hydrogels,
respectively. Use of crosslinking to control polymer swelling has been demonstrated
with

small

molecule

recognition

complimentary DNA recognition
recognition binding

[153]

.

[15]

binding

,

antigen-antibody

, protein-ligand binding

[152]

binding[150],

, and enzyme-substrate

Novel applications using hydrogel crosslinking to effect

swelling include: pulsatile protein release
[155]

[151]

[154]

, AND/OR logic gate swelling response

and quantum-dot fluorescence for label free DNA detection [7].
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1.3.2. Degradation
Another response that has been leveraged in the application of bioresponsive
hydrogels is the degradation of the polymer matrix in response to a biomediated stimulus.
Here, degradation is differentiated from erosion in that erosion occurs via hydrolytically
labile bonds such as ester, anhydride, or anhydride-co-imide bonds

[156-158]

. This is a

passive process dependent on environmental parameters pH and temperature; therefore it
will not be considered bioresponsive. For further information on eroding polymers the
reader is directed to Nair et. al [159].
Degradation is the breakdown of the polymer matrix into monomers and smaller
oligomeric chains. The transduction process in degradation is the breakdown of the
polymer backbone bonds resulting in the dissolution of the polymer network which
occurs by enzymatic cleavage. Enzymatically triggered degradation in drug delivery and
tissue engineering allows for targeted, controlled degradation of the polymer. The
triggered degradation of the polymer matrix is advantageous because the matrix can
remain in its native state until it is exposed to a specific enzyme. Degradation rates can be
controlled by varying concentrations of the enzymatically cleavable crosslinking
substrate, altering the sequence to increase or decrease its enzymatic affinity or reactivity,
or altering the morphology of the hydrogel matrix effecting enzyme access

[131, 160]

.

Degradation of bioresponsive hydrogels has been demonstrated by the triggered
degradation of multilayer polyelectrolytes
polysaccharide chains

[162]

[161]

, enzyme mediated hydrolysis of

and amide bond cleavage in peptides

[163, 164]

.

Novel

applications of degrading bioresponsive hydrogels have been demonstrated by in situ
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Figure 1-6: A bioresponsive hydrogel which gels in situ and degrades when exposed to
collagenase[6]. (A) Wet weight of non-degradable and degradable hydrogels exposed to
collagenase. (B) Wet weight of degrading hydrogels of varying degradable cross-linker
concentration. (C) Amino acid modified PEG-amine hydrogel. (D) Collegenase
cleavable cross linker. (E) Cell adherence peptide incorporated into PEG-succinimidyl
hydrogel.
polymerizing-degrading

[6]

hydrogels, Figure 1-6, and sensor-cell triggered, ruptured-

release of protein therapeutics [165].
1.3.3. Release
Release in bioresponsive hydrogels is considered a response and has been used
extensively as a vehicle for the delivery of therapeutic molecules. Biological triggers for
release include redox potential
of metabolites

[16]

[166]

, activity of biomacromolecules

[24]

, or concentration

. The transduction mechanisms for release are swelling or collapse of

the polymer network through ionic actuation or degradation
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[24, 167]

or the cleavage of

biologically active pendant groups

[9, 163]

. Using bioresponsive hydrogels as triggered

release vehicles allows for tighter control over the amount of drug being delivered, the
rate at which it is administered and can reduce unwanted side effects to ancillary systems
because the drug is localized only to desired regions and release is motivated by the
activity of a biomarker. Wilson et al. demonstrated enzyme actuated release through the
creation of a hydrogel-enzyme construct and explored covalent attachment loading and
controlled release rate though varying crosslink density [9]. The authors stoichiometrically
controlled the loading of a peptide-linked chromogen by varying the mole fraction of the
pendant, conjugatable amine group of co-polymerized 2-aminoethyl methacrylate
(AEMA). Release of the chromophore was mediated by exposure to chymotrypsin which
cleaved the covalently attached peptide. The release rate was controlled by changing the
cross-linker concentration, and in effect, the apparent diffusivity of chymotrypsin [168]. In
work by Lee et al., a virus mimetic nanogel was synthesized wherein targeting of tumor
cells, which overexpress surface folate receptors [169], was achieved by surface modifying
a bovine serum albumin-polyethylene glycol (BSA-PEG) shell and poly(L-histidine-cophenylalanine) core nanogels with folate ligands. After undergoing endocytosis the pH
responsive core would swell under endosomal pH and concomitantly release entrapped
doxorubicin and escape to the cytosol by disrupting the endosome membrane through the
proton buffering effect [149].
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1.3.4. Mechanical Release
1.3.4.1. Gelation
In situ gelation has become an emerging trend in the application and research of
bioresponsive hydrogels. Hydrogels that can cross-link in vivo following injection are
desirable because they can be implanted as solutions using a syringe and they can
negotiate close-fitting, tissue-to-gel contact in comparison to precast hydrogels.
Physically crosslinking and photo-crosslinking approaches have been demonstrated;
however, they have drawbacks such as low mechanical strength and the need for
cytotoxic photo-initiators, respectively. An alternative approach being explored is
enzyme mediated cross-linking of hydrogels

[12, 170]

. The gelation of such hydrogels

occurs by the linking of pendant groups through enzymes such as horseradish
peroxidase[171], phosphopantetheinyl transferase

[172]

, or tissue transglutaminase

[173]

Gelation rate was shown to be dependent on the ratio of enzyme to bioactive species

.

[12]

.

Hughes et al. have demonstrated gelation by self-assembly of dipeptide fibers and sheets
through enzyme mediated amide condensation of FMOC functionalized amino acids.
Morphology, mechanical properties, and yield were shown to be a function of amino acid
side groups

[174]

. For further discussion of in situ hydrogel formation, the reader is

directed to Van Tomme [175].
1.3.4.2. Shape Transformation
The shape of a hydrogel construct is known to effect drug carrier performance
[176]

. Engineering the ability to biologically trigger a shape change of a bioresponsive

hydrogel is of growing interest. As an example, spherical and elliptical hydrogels
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Figure 1-7: Temperature, pH, and chemically responsive hydrogel which changes shape
from an elliptical to a spherical configuration based on environmental conditions [3].
experience different hydrodynamic forces as they move through the vasculature.
Additionally, elliptical hydrogels have been shown to avoid phagocytosis more readily
than spherical hydrogels. While elliptical hydrogels are not phagocytosed as readily, they
also do not undergo endocytosis at the targeted cell as readily as spherical gels. This
makes it desirable to have an elliptical hydrogel in the vasculature, and then have a
spherical hydrogel near the delivery site [177]. To this end, bioresponsive hydrogels which
can change shape upon a tissue specific stimulus are being explored. In one construct, a
shape transformational hydrogel was created which changes from elliptical to spherical
orientation in response to pH, temperature and an analyte. The shape change is driven by
the balance of interfacial tension and polymer viscosity, Figure 1-7 [3].
1.3.5. Optical Response
Bioresponsive hydrogels that exhibit an optical response to a stimulus are gaining
traction as a viable platform for biodetection and biosensing. The mechanism for
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detection or sensing may result from swelling or collapse of the hydrogel matrix that
changes the shape of a lens

[178]

, changes the refractive index[179], gelation

or induces a change in absorption or emission

[181]

[180]

, turbidity,

. In each case the change in the

hydrogel matrix causes a detectable or measurable optical response. Additionally,
chromophores or fluorophores may be released pursuant to binding or become activated
by catalysis

[9, 18, 182]

. Responses can be visible by the naked eye or may require

measurements of absorbance or emission at specific wavelengths

[34, 180]

. In a more

recently developed system, thioglycolic-acid-capped quantum dots (CdSe QDs) were
covalently attached to an acrylamide based hydrogel microspheres that were cross-linked
with DNA motifs. When exposed to the complimentary strand of targeted DNA, the
binding of the DNA strands resulted in hydrogel collapse due to the uptake of
counterions. The collapsing event resulted in a blue shift in the Bragg diffraction peak.
This system proved to be highly sensitive, down to 1 nM, and could differentiate DNA

Figure 1-8: DNA sensing bioresponsive, quantum dot loaded hydrogel which elicits a
shift in its peak absorbance upon exposure to the complimentary target DNA [7].
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sequences that differed by one base pair, Figure 1-8 [7].
1.3.6. Electrochemical Response
Due to their high biocompatibility, hydrogels have been widely used in
biosensors, both as an interface between tissue and electrode and also as a host for
bioactive molecules[134]. By incorporating oxidoreductase enzymes into the polymer
matrix, the biospecificity of the enzyme is conferred to the transducer, and the enzyme is
stabilized in a hydrated 3-D milieu[183]. In amperometric biosensors, the electrodes act as
an eventual source or sink for the electrons being transferred by the enzyme. Biosensors
which measure analyte concentrations have been designed based on other electrical
properties such as potential or impedance

[35]

. To increase sensitivity, reduce interfacial

impedance, reduce interference from endogenous and exogenous species and improve
biocompatibility, electroconductive polymers such as polyaniline, polythiophene and
polypyrrole, have been synthesized into the voids of the hydrogel matrices

[35]

. The

resulting electroconductive polymer hydrogel composites also show the potential for
programmed release of loaded drugs under modest voltage stimulation.

This is

particularly useful in the development of prosthetic electrodes for deep brain stimulation,
intraocular implants and cochlear implants.

Another approach to facilitate electron

transfer in biosensors is the conjugation of the redox enzyme to single-walled carbon
nanotubes (SWNT). Enzyme-SWNT conjugates have been shown to increase the peak
current; additionally, graphene based biosensors are also being developed based on
similar principles[184,

185]

and may be incorporated into hydrogels. These composite

materials add new response modes to the bioresponsive hydrogels.
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1.4.

Conclusions
Bioresponsive hydrogels are increasingly being studied because they are highly

biospecific, and they exhibit controlled response that can be readily combined with
biomolecular recognition. Moreover, there are many technological opportunities in
targeted drug delivery, biosensors and regenerative medicine that motivate continued
energetic pursuit of devices based on bioresponsive hydrogels.

The application of

bioresponsive hydrogels is wide ranging, and they have been developed into tissue
engineering constructs, biosensors and targeted drug delivery vehicles.

Further

development of drug delivery devices can be achieved by engineering a system which not
only senses and responds, but couples the response to the triggering cue. Coupling the
response and trigger creates a molecular control loop, commonly seen in highly tuned
metabolic pathways, capable of actuating activity levels of a biological moiety to a
desired level. The use of these materials will continue to expand as they become coupled
and integrated with new technologies.
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CHAPTER TWO
2. TEMPERATURE DEPENDENT RELEASE MECHANISM OF MONO- AND DIVALENT IONS FROM PHOSPHORYLCHOLINE GROUP BEARING
HYDROGELS
2.1.

Introduction
Highly hydratable cross-linked polymers, or hydrogels, have become a mainstay

in biological and biomedical applications [186] due to their desirable properties engendered
by controllable high degree of hydration[187, 188], cell and tissue biocompatibility [189] and
high potential for molecular engineering

[190]

relative to other materials. A canonical

example of a hydrogel, poly(2-hydroxyethyl methacrylate) (pHEMA), was first used in
contact lenses for its optical clarity, dimensional stability, mechanical properties and
biologically benign nature [191]. Since then, hydrogels have expanded in molecular repeat
unit composition, architecture and applications to have technological impact in drug and
biomolecule theranostics

[192]

, multiplexed biomolecular detection

[192]

, biosensor-based

molecular diagnostics [193], drug free macromolecular therapeutics [194], tissue engineering
and regenerative medicine

[195]

. Moreover, hydrogels are continually being molecularly

engineered to serve as stimuli-responsive polymers

[8]

within their particular end-use

environments by exploiting various sense and respond mechanisms

[196-198]

. More

recently, feedback control has been integrated into bioresponsive hydrogels creating
synthetic analogs to tightly regulated metabolic pathways

[199, 200]

. While development,

application and commercialization of hydrogels moves forward, fundamental
understanding of their properties, interactions between the local bio-environment and the
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causal relationship between imbibed moieties and polymer structures are still an active
area of research

[197, 201]

. Controlled drug delivery is an area wherein fundamental

understanding of hydrogel-drug interaction allows proper design of polymers and
contributes to the successful development of drug delivery systems. The effects of
hydrogel swelling dynamics; solute transport properties; in situ kinetics of enzymatic
and/or binding recognition reactions; ionic interactions; and environmental (pH,
temperature, ionic strength) changes can alter the performance of a biologically
responsive system

[198, 202-204]

. These factors greatly influence polymer design and could

have unforeseen consequences on the release profiles of the delivered drugs, ultimately
impacting safety and/or efficacy.
Work done by Korseymer, Ritger and Peppas pioneered methods to study and
model drug delivery from polymeric hydrogel systems

[2, 205, 206]

. The culmination of this

early work, using pHEMA as the drug delivery polymer, was the combination of two
explicitly derived drug release models which describe diffusion controlled (Fickian or
Case I) and polymer relaxation controlled (Case II) release; Equations (29) and (30),
respectively. In general, polymeric hydrogels that do not exhibit appreciable relaxation or
for which the polymer segmental relaxation time is much smaller than the characteristic
diffusion time for solvent transport, experimentally display standard Fickian diffusion. In
this case, solvent transport is controlled by a simple concentration gradient and water
uptake by the polymeric hydrogel which exhibits the characteristic t1/2 dependence, with
the resulting swelling also exhibiting t1/2 dependence, Equation (29). When hydrogel
segmental relaxation is the dominant mechanism involved in solvent transport, then a
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time-independent hydration is observed and the swelling will depend linearly with time t,
Equation (30). Mathematically, these two release mechanisms have been shown to be a
function of t1/2 and t (first order), for planar hydrogel geometries, which can be used to
differentiate release mechanisms based on experimental observation. Previous work by
Alfrey et al. showed Equations (29) and (30) could be summed to describe the transport
of two species into a polymer matrix, one controlled through Fickian diffusion and one
controlled through polymer relaxation-driven swelling, resulting in Equation (31)

[207]

.

Finally, the heuristic combination of terms in Equation (31) has resulted in a semiempirical mathematical description, Equation (32), which has been shown to accurately
predict drug release profiles from planar, cylindrical and spherical geometries when
⁄

. Additional utility of the model is gained since the value of the

diffusional exponent, n, can indicate the predominant release mechanism; Fickian
diffusion or polymer relaxation. The diffusional exponent has been shown to vary based
on geometry and release mechanism as summarized in Table 2-1.
⁄

[

]

⁄

(29)
(30)

⁄

(31)
(32)

Where, Mt is the concentration of the released drug in the bathing solution at time t,
M∞ is the equilibrium concentration of the drug in the release solution, D is diffusion
coefficient, l is slab thickness, k1 is the diffusional rate constant which is proportionally
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related to D and l, k0 is the polymer relaxation constant, C0 is the initial concentration of
the drug, k2 is the swelling rate constant which is proportionally related to C0 and l, kKP is
the Korsmeyer-Peppas rate constant and

is the diffusional exponent.

Table 2-1: Diffusional exponent values for various geometries and release mechanisms
Slab

Cylinder*

Sphere

Release Mechanism

0.5

0.43

0.43

Fickian

0.5 < n <1.0

0.43< n <0.89

0.43< n <0.85

Anomalous

1.0

0.89

0.85

Case II

*Indicates an aspect ratio of 2.25. Aspect ratio relation to n is provided in Appendix‒A,
Figure‒2. Reprinted with permission from [2].
In many cases, however, rate balanced Fickian diffusion and polymer relaxation
or the presence of a third component that contributes to overall system dynamics; e.g. an
analyte for a sensor or a drug molecule for release, can result in an intermediate type of
transport mechanism, which is referred to as anomalous transport

[208]

. To build upon

previous work and expand the utility of the model developed by Korseymer, Ritger and
Peppas, we

[209, 210]

and others

[211]

have been investigating the transport of charged

species within hydrogels. Of particular interest is ion transport within pHEMA-based
hydrogels containing biomimetic, zwitterionic moieties such as phosphorylcholine.
Phosphorycholine, the polar head group of the outer leaflet of cell membranes, has
emerged as a biomimetic moiety for conferring cyto-compatibility to hydrogels

[212]

. The

study of ion transport within such hydrogels under test conditions that emulate
physiological conditions could potentially inform various pathologies associated with ion
transport across biological membranes. Moreover, ion transport within hydrogels is
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important in the design and application of wetting and disinfection agents for soft contact
lenses, in controlling ocular drug delivery, in separation applications based on solute
partitioning and in analytical techniques that employ hydrogel pre-concentration. Here
the authors have investigated the effects of temperature, cation valence and swelling
dynamics to determine the contribution of these factors to cation release kinetics.
To investigate the effect of valence, monovalent (potassium) and divalent
(calcium) cations were released from a phosphorylcholine containing p(HEMA)-based
hydrogel matrices. Such electrostatic migration is aptly described by the Nernst-Planck
equation, Equation (33)

[142]

. Numerical solutions to the Nernst-Planck equation can be

realized by coupling potential field effects through the Poisson equation, Equation (34)
[142, 143]

. While finite element modeling approaches have been successful in reproducing

experimental results to simplified systems using these equation, explicit relationships
have not been resolved for the coupled transport phenomena. Experimental approaches
are being taken to tease apart the importance of contributing phenomena to understand
the role of charge density of the ion and hydrogel, the hydrodynamic radius of the ions
involved, polymer relaxation dynamics and the molecular weight between crosslinks of
the hydrogel that governs its mesh size.
(

)
∑ (

)

(

)

(33)
(34)

Where Ci is the concentration of species i, Deff is the effective diffusivity, z is the
valence of the ion, μ = FDeff/(RT) is the unsigned mobility, ψ is the electrical potential, v
is the velocity of the solvent, ri is the reaction term, F is Faradays constant, ε0 is the
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permittivity in free space, εr is the dielectric constant, Nf and Nb are the numbers mobile
and bound species, respectively.
To realize these distinctions, ions may be introduced into hydrogels during
formulation alongside monomer and pre-polymer constituents prior to crosslinking (presynthesis loading). Alternatively, ions may be introduced into hydrogels by partitioning
into the fully-hydrated, equilibrium-swollen hydrogel (post-synthesis loading). In
addition, the effect of temperature was investigated by monitoring ion release over a
temperature range of 25-45°C. In this work a 3 mol % tetraethyleneglycol diacrylate
(TEGDA) cross-linked biomimetic poly(2-hydroxyethyl methacrylate) (pHEMA)-based
hydrogel was synthesized to contain 2-methacryloyloxyethyl phosphorylcholine (MPC)
units (1 mol %) and poly(ethylene glycol) (400) monomethacrylate (PEG(400)MA) (5
mol% ) cast into short cylindrical microforms. Both MPC and PEG constituents play a
role in conferring biomimetic cyto-compatibility to the hydrogel [213, 214]. The transport of
monovalent potassium cations (K+) and divalent calcium cations (Ca++) was studied
under two conditions. Firstly, ions in the form of the powdered chloride salt were loaded
into the hydrogel during formulation and prior to UV crosslinking. Secondly, ions in the
form of an aqueous solution of the chloride salt were partitioned into the blank hydrogel
during equilibrium hydration of the previously synthesized microform. Temperature
dependent release of ions was studied at 25, 31, 37 and 45oC using calibrated ion
sensitive electrodes (ISEs).
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2.2.

Experimental Section

2.2.1. Reagents
Anhydrous calcium chloride (CaCl2, ≥99.99%) and potassium chloride (KCl,
≥99.0%) were purchased from Sigma Aldrich (Milwaukee, WI, USA). The hydrogel
components: HEMA, PEG(400)MA, the divalent cross linker, TEGDA, and the
photoinitiator, 2,2-dimethoxy-2-phenylacetophenone (DMPA, 99%), were also purchased
from Sigma Aldrich. The biomimetic reagent 2-methacryloyloxyethyl phosphorylcholine
(MPC) was prepared elsewhere as previously described

[215]

. The removal of

polymerization inhibitors hydroquinone and monomethyl ether hydroquinone from the
individual cocktail components proceeded by passing the liquid monomers over an
inhibitor removal column. The buffer of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid sodium salt (HEPES) was prepared to physiologically relevant conditions (pH = 7.4;
ionic strength = 160 mM)

[216]

. HEPES buffer was firstly prepared to 100 mM and then

titrated by the addition sodium hydroxide (NaOH) to a concentration of 50 mM. Finally,
the ionic strength of the buffer was adjusted by the addition of sodium chloride (NaCl) to
a concentration of 160 mM. Deionized (MilliQ DI, Billerica, MA, USA) water was used
to prepare all of the solutions.
2.2.2. Preparation of Monomer Cocktail and Synthesis of Hydrogel Disks
Hydrogel pre-polymer cocktails were prepared by combining monomer
constitutes in the mol % outlined in Table 2-2. To improve solubility, ethylene glycol and
water were added to the mixture in a 1:1 (v/v) ratio such that the two species combined
comprised 20 volume % of the formulation. After combining constitutes, the mixture was
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ultrasonicated for 5 minutes and sparged with nitrogen to remove dissolved oxygen.
Hydrogel discs were fabricated by placing silicone isolators (JTR12R-2.0, Grace Biolabs,
Bend, OR, USA) onto trichloro(octadecyl)silane(OTS)-treated hydrophobic glass
microscope slides and 31 µL of hydrogel pre-polymer was pipetted into the individual
silicone isolation chambers and a second hydrophobic glass slide was placed on top of the
silicone thereby sealing the liquid cocktail into the chambers between hydrophobic
surfaces. The hydrogel-containing, sandwiched isolation chamber was immediately
placed in a crosslinker (CX-2000, UVP, Upland, CA, USA) and UV irradiated at 366 nm
for 10 min to initiate polymerization. The polymerized discs were then removed,
retaining the form dimension of the chambers (thickness l = 2.0 mm and radius a = 2.25
mm), and stored at 4°C until use. Figure 2-1A, B and C show a representation of the
resulting macromolecular network structure, a hydrated hydrogel disc and the
sandwiched silicon isolation chamber, respectively.
Table 2-2: Composition used in prepolymer formulation for ion release studies.
Hydrogel Constituent
HEMA
TEGDA
PEG(400)MA
MPC
DMPA
*Mol % calculated for repeat unit.

Mol Percent of Hydrogel (%)
90.0
3.0
5.0*
1.0
1.0
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Figure 2-1: Schematic of the molecular structure and mol% composition of the prepolymer constituents of poly(HEMA)-based hydrogel possessing MPC, PEG(400)MA
and cross-linked with 3 mol% TEGDA.
Loading of the hydrogel discs with the salt species, CaCl2 or KCl, proceeded
through two methodologies. The first method, pre-loading, was achieved by dissolving
the salts in the pre-polymer cocktail at a concentration of 100 mM. One pre-polymer mix
was created for each salt. Dissolution of the salt was achieved by ultrasonication for 10
min followed by stirring overnight. The second method, post-loading, proceeded by
bathing the hydrogel disc in a 100 mM solution of the respective salt at the temperature
of the release experiment. Hydrogel discs that were formulated to contain CaCl2 and KCl
for the pre-loading experiments were used in subsequent post-loading experiments, after
the pre-loading experiment had occurred, and were only bathed in salt solutions that
contained their respective preloaded salt. To ensure the polymer achieved equilibrium
with the loading solution, hydrated disc weight was monitored hourly until the weight
stabilized which took 2-4 hours, typically.
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2.2.3. Experimental Setup for Release of Charged Species
Prior to release, a calibration curve for each ion selective electrode (ISE) (ColePalmer ISE Electrode SC-27502-09 and YO-27504-26) was created by duplicate
measurement of the voltage response to serial dilutions of CaCl2 or KCl in HEPES buffer
at each temperature, Appendix‒A, Figure‒1. The calibration curve was used to convert
voltage release data to concentration based on the Nernst equation. The voltage response
from the ISE was collected using a Model DI-155 data acquisition interface (DATAQ
Instruments, Inc., Akron, OH, USA) and associated software which recorded and ported
the data to MS Excel. Release of the pre- or post-loaded Ca++ or K+ cations was initiated
by placing the loaded disc into a temperature equilibrated scintillation vial containing
3mL of HEPES buffer and the appropriate ISE. To ensure ideal sink conditions, the
release volume (100 times the disc volume) was constantly stirred during release and
maintained at a constant temperature. Release experiments were performed in replicates
of 3-12 per experimental setup.
2.2.4. Calibration and Performance of ISEs
ISEs are convenient for this type of ion release study as they generally have
excellent response times, are quite stable and may be readily interfaced to data
acquisition systems. However, ISEs do have a narrow temperature performance window.
Accordingly, each ISE used was calibrated at each of the several temperatures of this
study. Appendix‒A, Figure‒1, shows the calibration curves obtained for duplicate runs
over five decades of concentration at 25, 31, 37 and 45 °C. There is a clear linear trend of
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increasing slope expected for the behavior of ISEs; however, the slopes obtained did not
comport with the expected Nernst value.
2.2.5. Hydrogel Characterization
Gravimetric hydrogel characterization was performed to determine Swelling% and
Degree of Hydration (DoH) of the hydrogels in HEPES buffer or HEPES buffer
containing different concentrations of the salt KCl or CaCl2 between 25 and 45oC. To
calculate Swelling%, Equation (35), the hydrogel discs were weighed on a microbalance
in their hydrated (H) and dehydrated (D) states. Swelling%, were determined immediately
before and immediately after release of ionic species at various temperatures by
measuring the weight of the hydrogel disc at those times (Sb – before and Sa - after). The
difference in Swelling% as a result of the release was determined from the before and
after measurements and was calculated using Equation (36). DoH was calculated using
Equation (37).
(35)
(36)
(37)
Where MH is the weight of the hydrated hydrogel in HEPES buffer, MD is the
weight of the dehydrated hydrogel and MS is the weight of the hydrogel immediately
before (MSb) or immediately after (MSa) release of the ionic species.
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2.2.6. Analysis of Release Profiles
It was previously shown that release of Ca++ and K+ ions from TEGDA crosslinked p(HEMA)-based hydrogel containing phosphorylcholine groups was best
represented by the Korsmeyer-Peppas model

[209]

. Accordingly, nonlinear least squared

(NLLS) fits to Equation (32) were performed for all release profiles obtained. Data fitting
⁄

used the portion of the release curve where

. Statistical analysis was

performed using Matlab (2012a) to determine statistical difference of parameters kKP and
n for loading, ion type and temperature groups. The analysis used a nested ANOVA
approach with temperature as a nested, random variable and ion type and loading method
as the main, fixed variables. The nested design is provided in Appendix‒A, Table‒1.
Tukey HSD was used to determine if composite values of n were statistically different
from each other and a multi-comparison test with the Bonferroni correction was used to
determine if they were different from their theoretical values. Regression analysis was
performed using MS Excel Data Analysis Tool Pack.
2.3.

Results and Discussion

2.3.1. Release Profiles
Figure 2-2A-D show the normalized release profiles of calcium and potassium
ions from pre-loaded and post-loaded hydrogels into pH 7.4 HEPES buffer at 25, 31, 37
and 45 °C. The molar concentration of the appropriate ion in the release solution at a
given time, Mt, was determined from the acquired voltage vs. time data by use of the
experimentally prepared calibration curves. The Mt value was normalized to the
equilibrium ion concentration in the release solution, M∞, and plotted as a function of
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Figure 2-2: Normalized release profiles of pre- (A&C) and post- (B&D) loaded Ca++
(A&B) and K+ (C&D) ions from pHEMA hydrogel disks.
time for each temperature studied. Normalization was used to eliminate release
dependence on the initial ion concentration in the hydrogel disc and for fitting to
Equation (32). Visible from the release profiles, it is apparent that calcium exhibits a
much faster release than potassium from pre- and post-loaded hydrogels. The subsequent
discussion seeks to illuminate possible reasons for the observed phenomena, such as
different mechanisms of release.
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2.3.2. Cation Effects on Release and Polymer Structure
The non-linear least squared fit of the release profiles with Equation (32)
generated constants, n and kKP, which were subsequently analyzed to determine the effect
of cation valence on the release profiles. Composite values of the diffusional exponent, n,
and the release rate constant, kKP, were calculated for K+ pre-loaded, K+ post-loaded, Ca++
pre-loaded and Ca++ post-loaded gels.

Figure 2-3A shows the results of these

calculations where values of n for K+ (blue bars) are clearly at or below the threshold for
Fickian transport and values of n for Ca++ (red bars) are clearly Case II and anomalous
transport. To reinforce these graphically obvious findings, a multiple comparison (Tukey
HSD) test was performed to determine statistical difference between the groups. At 95%
confidence, it was shown that there was no statistical difference in the diffusional
exponents for pre- vs. post-loaded hydrogels when potassium was the released ion while
there was a statistical difference when calcium was the released ion (p >0.05).
Additionally, it was shown that values of n for K+ and Ca++ were statistically significantly
different in both the pre- and post-loaded cases (p <0.05). This indicates that cation
valence clearly has a significant effect on the mechanism of release. A second multicomparison (LSD with a Bonferroni correction) test showed that values of n for preloaded K+ were not statistically different than 0.43 indicating that the hydrogels
containing K+ exhibited release profiles predicted by Fickian diffusion. Additionally,
post-loaded K+ release profiles resulted in values of n that were statistically lower than
the Fickian value of n = 0.43. For post-loaded Ca++ the diffusional exponent was not
statistically different that 0.89 indicating the hydrogels with post-loaded Ca++ exhibited
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release profiles that were consistent with a Case II type release behavior. Finally, the
hydrogels possessing pre-loaded Ca++ had n values that were found to fall between 0.43
and 0.89 indicating anomalous release behavior.

An alternate statistical analysis

accounting for subsampling, nested ANOVA, supported these findings, Table 2-3.
Table 2-3: Nested ANOVA for the effect of loading method, ion type and temperature on
n and kKP.
Nested ANOVA for Diffusional Exponent (n)
Source
SS
Loading
0.2371
Ion
3.1399
Temp(Loading,Ion)
1.0551
Error
4.5592
Total
8.7794
Nested ANOVA for rate constat (kKP)
Source
SS
Loading
0.0012
Ion
0.1763
Temp(Loading,Ion)
0.0892
Error
0.2583
Total
0.5187
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d.f.
1
1
13
98
113

MS
0.2371
3.1399
0.0812
0.0465

F
3.12
41.28
1.74

P
0.0970
0.0000
0.0634

d.f.
1
1
13
98
113

MS
0.0012
0.1763
0.0069
0.0026

F
0.18
28.23
2.6

P
0.6739
0.0001
0.0038

Figure 2-3: (A) Composite diffusional exponent, n, values for different ion and loading.
Where * indicates statistical significance (p<0.05), ‡ indicates not statistically different
than Fickian value of n (0.43) and † indicates not statistically different than Case II value
of n (0.89). (B) Composite rate constant, kKP, value for various ion and loading. Shaded
region indicated range of kKP values found elsewhere for water transport in hydrogels [4].
(C) Diffusional exponent values for hydrogels which do not (empty) and do (filled)
contain MPC.
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The dependence of n on ion valence suggests that the interaction between the
mono- or di-valent ions and the zwitterion containing polymer are quite different, and this
interaction influences not just the release profile but the release mechanism. The
interactions between the ions and polymer which affect the release profile may be
understood with polymer swelling theory and polymer dynamics. The theory, developed
by Flory and Huggins, originally described environmental effects of entropic polymer
relaxation (rubber elasticity theory)[80,

217]

and free-energy dependent swelling

(equilibrium solvation theory)[97]; however, it has been extended to include cationic,
anionic and pH sensitive hydrogels

[218]

. The free energy of the system, ΔG, can be

expressed as a function of the free energy of elastic deformation, ΔGel, polymer-solvent
mixing, ΔGmix, and ionic contributions, ΔGion, Equation (38). Furthermore, the osmotic
swelling pressure of a swollen polyelectrolyte gel, which is equal to the osmotic pressure
of the solution at equilibrium, may be written as a function of the pressure contribution of
these terms, Equation (39) [219, 220] .
(38)
(

)

(

⁄

)

(39)
(

)

Where R is the ideal gas constant, T is temperature, V1 is the molar volume of the
solvent, φ is the volume fraction of the polymer, χ is Flory-Huggins interaction
parameter, A is a constant of order unity, v is the concentration of network chains, i is the
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fraction of charged monomers, Vm is molar volume of the monomer and cgel and csol are
the concentrations of added salt in the gel and solution at equilibrium, respectively.
Work by Horkay et al.

[220]

used this theory to demonstrate the interaction of an

anionic polyelectrolyte hydrogel, sodium poly-acrylate cross-linked with N,N′methylenebis(acrylamide), with alkaline metal salts (LiCl, NaCl, KCl, and CsCl),
alkaline earth metal salts (CaCl2, SrCl2, and BaCl2) and rare earth metal salts (LaCl3 and
CeCl3). The key findings of their work, applicable to ion release from zwitterionic
hydrogels, were; i) that the alkaline and alkaline earth metals do not contribute to the free
energy of elastic deformation; subsequently, it was proposed that neither strongly interact
to form cross-links with anionic pendent groups of the polymer. ii) Through first and
second order Flory-Huggins interactions parameters, it was shown that the alkaline
metals do not contribute to the free energy of mixing, ΔGmix, while the alkaline earth
metals do contribute to this parameter. The entropically driven ion exchange between the
polymer and different classes of aqueous solvated metal ions has been observed by others
[221]

, explained by the higher valence number of the alkaline earth metals as this allows

them to interact more strongly with negatively charged moieties on the polymer
backbone, relative to alkaline metals. The alkaline metals do not contribute to polymersolvent interactions, and conversely, alkaline earth metals form polymer-ion complexes
through charge-charge interactions between the divalent cations and the anionic
polyelectrolyte. Studies of the sulfobetine containing polymer, poly(N/N-dimethyl
(methacryloyloxyethyl) ammonium propane sulfonate) and sulfobetine brushes

[222-224]

likewise show the independence of monovalent cation action. Similar observations were
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made for the swelling behavior of poly(MPC) that had been immersed in Li +, Na+, K+,
Ca++, Mg++ and NH4+ as the chloride salt. [225]. While physical properties, such as charge
density and hydrodynamic radius, differ, the primary cause of the polyplex formation is
determined by the valence of the ion [209, 220]
Diffusional exponent values reported here are consistent with the findings by
Horkay et al. [220]. In both cases, hydrogels produce release profiles for K+ ions reflective
of Fickian diffusion and which are expected for non-interacting entities being released
from a hydrogel. On the other hand, Ca++ release profiles demonstrate Case II or
Anomalous release, apparent by the t1 dependent release profiles, suggesting the
influence of relaxation of ion-polymer complexes must occur for divalent cation release.
Further evidence for this hypothesis is found from an investigation of the hydrogel degree
of hydration. The DoH, which is related to φ, is presented as a function of the bathing salt
concentration in HEPES, Figure 2-4. Hydrogels bathing in both KCl and CaCl2 solutions
exhibited salt concentration dependent reduction in DoH; however, hydrogels in the KCl
solution retain more water than the gels in CaCl2 as salt concentration was increased. The
decrease in DoH for gels in KCl solution can be explained by the osmotic pressure of the
salt, represented by the term Πion in Equation (39). Hydrogels in CaCl2 solutions show a
greater decrease in DoH as a function of salt concentration since swelling of the gels is
affected by Πmix in addition to Πion.
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Figure 2-4: Degree of hydration for hydrogels as a function of the bathing solution salt
concentration and temperature.
To investigate the possibility of an interaction between either of the two
respective mono- and di-valent ions, potassium or calcium, and the zwitterionic MPC
groups, pre-loaded hydrogels were formulated which did not contain MPC (0 mol %
MPC) and the diffusional exponents were determined from their release profiles as
previously described. A comparison of the n values obtained from hydrogels containing 0
mol% MPC and 1 mol% MPC is shown in Figure 2-3B. When the same ion was tested,
there was no statistically significant difference between the values of n for hydrogels
which contained 0 mol% MPC (empty bars) and 1 mol% MPC (filled bars). An
examination of the diffusional exponents across cation valance but within the same
polymer formulation revealed a statistically significant difference. The transport
exponents for release from hydrogels which contained 1 mol% MPC but had different
ions loaded into the polymer were significantly different. That is, the mechanism of
release of K+ and Ca++ from 1 mol% MPC containing hydrogels was convincingly
different. The K+ ions were released by a Fickian transport mechanism while the Ca++
ions were released by an Anomalous or Case II transport mechanism. Finally, a similar
53

comparison was made for 0 mol% MPC hydrogels with the two different ions. In this
case statistically significance difference in the transport exponents was not shown. This
indicates that both the presence of MPC and the valence difference between the two ions
was required in order to establish a different release mechanism in pre-load hydrogels. It
is believed that the presence of the Ca++ ions facilitates the formation of the PC based
polyplexes [226].
As with the diffusional exponent, n, the rate constant, kKP, was shown to be
significantly different for ion valence (p value < 0.05) but not for loading methods,
Figure 2-3C. That is, the loading method did not appear to alter the mechanism of release.
The values for kKP do not fall within a range of values, 0.0028 - 0.0332 (s-n), reported
elsewhere for the transport of H2O into pHEMA-based hydrogels at pH 7.0

[4]

. In the

cited study, the diffusional exponent was found to range from 0.369 - 0.556, indicative of
a Fickian diffusion release mechanism. The comparison of the rate constants of between
H2O and K+ is of particular interest since the normalized released profiles are both linear
with respect to t1/2 but produce drastically different rate constants. A potential explanation
for higher kKP values for charged vs. neutral species may be found in the electromigration
term. Currently, electromigratory effects under the influence of the ζ-potential of the
microform, have not been put into the mathematical context of Equation (32), so behavior
of n or kKP via gradient potential release is not available; however, if diffusion and
electromigration have similar theoretical transport exponents, the rate constants would
become additive, Equation (40).
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(

)

⁄

(40)

Where kF and kE are the rate constants for Fickian diffusion and electromigration,
respectively. The higher values of kKP for K+ relative to H2O could be explained by the
additional driving force of electromigration if these effects are additive. Ca++ has a value
of kKP between K+ and H2O. Since Ca++ release mechanism is Case II or Anomalous, the
contribution of electromigration to kKP may be attenuated as it follows a t1 rather than a
t1/2 dependence. For electromigration to occur, a potential driving force must exist in the
system.

Three possible sources of a field are hypothesized to be:

i) shielding of

negatively charged groups on the hydrogel resulting in increased positively charged
groups which would electrostatically repel positive ions (pKa PC = 7.2

[227]

); ii) charge

separation between positive and negative ions due to different effective diffusivities
resulting in temporal potential gradients; iii) difference in charge distribution across the
hydrogel-solution interface. It is unclear if the different kKP values are caused by the
contribution of an electromigratory effect or other factors, such as polymer composition.
Further mathematical relations and experimental work will need to be explored to
investigate the effects of electromigration on the rate constant of release.
2.3.3. Temperature Effects on Release
Figure 2-5A shows the diffusional exponent as a function of temperature for both
cation type and loading method. Temperature dependence of n suggests the mechanism
of release is thermally activated while temperature independence suggests the mechanism
of release is not thermally activated over the temperature range studied. For hydrogels
55

that were pre- or post-loaded with K+, a temperature independence, determined by
regression analysis of the slope (p>0.05), of n values was observed suggesting the
mechanism of release is consistently Fickian over the temperature range. Temperature
dependence of n values is observed for Ca++ pre-loaded hydrogels (p<0.05) which
explains the previously discussed anomalous value of n reported for the composite of the
values, Figure 2-3A. The value of the diffusional exponent for Ca++ pre-loaded hydrogels
is Anomalous at low temperatures (25 and 31oC) and moves towards a Fickian value for
higher temperatures, 37 and 45oC. This suggests that at lower temperatures there is not
enough thermal energy to disrupt the cation and polyelectrolyte complexes. Placing the
hydrogel disc into the buffered solution increases the chemical potential difference
between the cation and its surrounding environment; subsequently, the complexation sites
are relaxed releasing the cation into void spaces within the hydrogel where it then
diffuses out. An increase in temperature correspondingly increases the thermal energy of
the cation-polyelectrolyte complexes, at high enough temperatures; the thermal energy
will be enough to disrupt this interaction. This will create solvated Ca++ cations that are
not hindered by the PC polyplexes and therefore readily diffuse out producing a Fickian
release profile. Notably, pre-loaded Ca++ was released more quickly at low temperatures
than at high temperatures. While the decreasing n value suggests the opposite to occur,
decreasing kKP values also contribute to the predicted profiles and can account for this
discrepancy.
The release of Ca++ that were post-loaded into hydrogels exhibit temperature
independence (p>0.05) and exhibit n values consistent with Case II transport over the
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temperature range. Since the post-loading occurred through partitioning, it is possible that
the majority of the loaded Ca++ was incorporated into the hydrogel through complexation;
conversely, the pre-loaded hydrogels did form substantial aggregation sites since the
polymer chains and Ca++ ions may have restricted mobility in the low hydration state of
the polymer immediately following polymerization. This would reduce the number of
complexation sites being relaxed during release and increase the amount of free Ca++
available for release though a hindered-Fickian mechanism.
Temperature dependence of kKP was investigated through analysis of Arrhenius
plots. Figure 2-5B shows a decrease in the value of kKP with increasing temperature for
K+ release while the value of kKP remains constant with temperature for Ca++ release [209].
The unaltered kKP values were used in the Arrhenius plots. Apparent activation energies
for release of K+ and Ca++ were determined from the slope of the Arrhenius plots, Figure
2-5C, and were calculated to be -19±15 and -17±20 kJ/mol, respectively.
Regression analysis of ln(kKP) vs. Temperature-1 showed the slope for potassium
was statistically different than zero (p < 0.05) while the slope for calcium was not
statistically significantly different than zero (p > 0.05). This indicates that the calcium
release does not exhibit temperature dependence over the temperature range investigated
while potassium release does display temperature dependence over the same range. The
decreasing kKP values vs. temperature and the negative activation energy are of interest
as, it is known that diffusivity, calculated to be 2.03×10-5 and 3.90×10-6 cm2/s using
Equation (41) for pre-loaded potassium and calcium, respectively,
charge carriers increase exponentially with temperature
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[229]

[228]

and mobility of

. The source of the negative

apparent activation energy is currently unclear; however, complexities arising from ion
transport within the hydrogel may contribute to the phenomena. One potential complexity
that could explain the negative activation energy is offered by consideration of polymer
swelling as a function of temperature. Figure 2-4 shows temperature dependence in the
DoH for hydrogels bathing in KCl and CaCl2 salts. While the dependence appears nonlinear, hydrogels at 37 and 45oC demonstrated a lower DoH than gels at 25oC. Invoking a
porous media model of transport, Equation (42), it is clear that Deff is a function of DoH
through void fraction, Equation (43)

[198]

. Since DoH of the hydrogel decreased as

function of temperature, the effective diffusivities will correspondingly decrease which
would result in a negative apparent activation energy. This consideration is clearer for
K+ as it follows Fickian release; however, Ca++ has additional effects of polymer
interactions and subsequently is a more complex system which may explain the
difference in the temperature dependence of the two ions. Trongsatitkul et al. observed
similar negative activation energies for FITC-dextran release from PNIPAm and
contributed the phenomena to a denser polymer at higher temperatures, similar to the
explanation provided here, and adsorption/desorption processes which competed with
Fickian diffusion for the available kinetic energy to activate the processes [230].
⁄

(

)

(41)
(42)

(

⁄

)

(43)
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Where Kp is the portioning coefficient, KR is the reflection coefficient, D0 is the
diffusivity in buffer, ε is polymer void fraction, τ is the tortuosity and ρHG and ρsol are the
densities of the hydrogel and solution, respectively, and n = 0.43. For ion transport, in
order to maintain electro-neutrality within the hydrogel, as the ions are transported out of
the hydrogel, their counter anions must simultaneously electromigrate. Since calcium is a
divalent cation, twice as many counter anions must simultaneously electromigrate. This is
in contrast to only one counter anion for the electromigration of potassium. While is this
simplified view, which may be justified in water and below the dilute solution limit, this
model is rendered complicated by; i) the distribution of appropriate voids within the
hydrogel, ii) the solvating influences of free and bound water within the hydrogel, iii) the
number, distribution and nano-architecture adopted by the charged moieties associated
with the zwitterionic pendant groups of hydrogel and iv) the membrane potential gradient
across the polymer–buffer interface. Since multiple processes may be contributing to
these apparent activation energies more complex model may be needed to interpret the
values.
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Figure 2-5: (A) Diffusional exponent, n, as a function of temperature. (B) Rate constant,
kKP as a function of temperature. (C) Arrhenius plots of kKP for potassium and calcium,
respectively.
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2.3.4. Hydrogel Swelling and its Effects
Theory resulting in Equation (32), allows experimental determination of release
mechanism from hydrogel matrices by examination of the diffusional exponent. The
degree of polymer swelling which occurs during release, ΔSwelling%, was measured at
temperatures 25 and 37oC, as shown in Figure 2-6. For both ions it was found that an
appreciable change, Δ = 16 to 23%, in Swelling% occurred for the preloaded hydrogels.
This is expected as the preloaded discs begin in an un-hydrated state and subsequently are
further away from equilibrium. Conversely, the post-loaded hydrogels demonstrated a
minimal ΔSwelling%, Δ = -8 to -2%, with only one, calcium at 25oC, having a
statistically significant change (p < 0.05) in Swelling% during the release. Interestingly, a
reduction in the Swelling% was observed for the post-loaded discs, which was
unexpected since as t→∞, Swelling%→100%. The cause of this initial reduction is
unknown; however, it is hypothesized that it may be due to the weight loss of the salts
within the polymer matrix. Further experimentation needs to be performed to test this
conjecture.
Statistical analysis of the composite values showed no difference between the
diffusional exponents for pre- and post-loading methods when potassium was the
released ion. Since K+ release was shown to be unaffected by polymer relaxation, this
result is expected. For Ca++ release, which did demonstrate polymer relaxation effects,
interpretation of the diffusional exponent for pre- and post-loading can be used to glean
insight to the relation between polymer swelling and relaxation. If n values were reduced
for the post-loaded relative to the pre-loaded, it would have indicated the removal of
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polymer swelling phenomena removed the polymer relaxation effects on the release
mechanism. Since this did not occur and the n values for post-loaded Ca++ release
exhibited values predicted by Case II type release, it is concluded that polymer relaxation
and polymer swelling are two independent processes and only the former effects ion
release. During polymer relaxation, polymer pendent groups reorganize to reduce
mechanical strain and relieve complexation sites while in polymer swelling the
mesoscopic structure of the polymer is changing to accommodate a high water content to
balance osmotic and mechanical forces. The latter happens on a time scale much longer
than ion release and subsequently does not play a contributing role in the release
mechanism.

Figure 2-6: K+ and Ca++ releasing hydrogels’ ΔSwelling% for pre- and post-loaded
release.
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2.4.

Conclusions
In this work the release profiles of K+ and Ca++ from zwitterionic, pHEMA based

hydrogels were studied. The contribution of polymer relaxation, valence state and
temperature to the diffusional exponent and rate constant were investigated. It was shown
that ion charge played the most significant role in the mechanism of release. This is
primarily caused by a weak interaction between divalent cations and polyelectrolyte
anions forming polymer-ion complexation sites which govern release. This interaction is
not observed for monovalent ions and subsequently the mechanism of release is different.
Moreover, it is shown that the presence of both MPC and a divalent cation is necessary to
experimentally observe the interaction.

Temperature dependence of the diffusional

exponent was observed for calcium but not potassium. This is likely due to a transition
between case II type and Fickian type release for calcium. The cause for the transition is
the increase of thermal energy which disrupts the polymer-ion complex. It was
additionally shown that K+ diffusivity constants followed Arrhenius type activation with
apparent activation energy of -19±15 kJ/mol. Conversely, kKP for Ca++ did not
demonstrate a temperature dependent relation. The apparent negative activation energy is
not fully understood by, but it is not due to diffusion or ion mobility. Temperature
dependent polymer swelling is a proposed hypothesis for the negative apparent activation
energy. Statistical analysis showed differences in the release rate constant for each ion.
The observed values are much higher than for neutral molecules, and it is proposed that
the increase is primarily due to electromigration. This work demonstrates the KorseymerPeppas release equation is an adequate model for the prediction of ion release from
63

zwitterionic hydrogels; however, the work has shown other factors such as
electromigration may play a role in ion release from hydrogels. Mechanistic phenomena
were investigated through the diffusional exponent further demonstrating the utility of the
equation. While fundamental phenomena of ion release from hydrogels has been
elucidated here, further mathematical and experimental investigation of this system will
be required to produce a more complete theory involving electromigratory effects.
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CHAPTER THREE
3. TARGETING HOMEOSTASIS IN DRUG DELIVERY USING BIORESPONSIVE
HYDROGEL MICROFORMS
3.1.

Introduction
Hydrogels are polymers synthesized from highly hydrophilic monomers and/or

pre-polymers into networks that imbibe large amounts of water, are passively
biocompatible due to their favorable interaction with extracellular matrix (ECM) proteins
and are highly versatile in their range of possible biotechnical applications that exploit
their swelling and de-swelling dynamics

[186]

. Because of these characteristics, hydrogels

have been extensively studied for a wide range of biomedical applications that include
controlled drug delivery

[202, 231, 232]

, tissue engineering and regenerative medicine

and diagnostic biomedical biosensors

[234-236]

[29, 233]

. Hydrogels have also evolved over the

years through several generations wherein increased conferred functionality, control of
polymer architecture and improved processing has enabled new and innovative
applications resulting in the moniker of “smart materials”. Among these smart
applications is one wherein the ability to sense and react with a biological entity is
integrated with the physicochemical responses of the hydrogel. Biologically responsive,
or bioresponsive, hydrogels operate by first sensing the chemical activity of a biological
specie in its environment, through catalysis or binding, and then couples the biomolecular
recognition to transduction of that information with a response that seeks to restore
equilibrium or a pseudo-steady state within the hydrogel

[198]

. In this sense, they are

Generation 2 drug release platforms that supersede Generation 1 drug release platforms,
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which rely on loading and passive release of a drug from an engineered microform. Of
particular interest is the use of micro- and nano-hydrogels to sense and respond to
spatiotemporal perturbations of biological activity as this enables the development of
therapeutics and diagnostics at molecular and cellular length scales. Such systems are
well described and are actively pursued in the literature. The development of drug
delivery systems that are based on self-regulation and that are made responsive to an
externally derived or environmentally-based biological activity that dictates the release
rate of the drug has long been a goal of drug delivery designers

[237]

. This is particularly

relevant in glucose-responsive insulin delivery, wherein the rate of release of insulin may
be governed by the bathing concentration of glucose, analogous to an all synthetic
artificial pancreas

[238]

. Recently, an in vivo demonstration of this objective that uses the

glucose(sense)-insulin(deliver) system was reported; however, engineering control of key
delivery parameters of such systems are unexplored [239].
Generation 3 drug delivery systems go beyond environmental control of the
release rate to focus attention on achieving physiological stasis of the biological species
that is the target of drug action. Self-regulated delivery systems imply a nascent ability to
change release profile pursuant to the amount of or extent of release. Generation 3
systems use the released drug to modulate the activity of the actuating biological factor.
In this sense, it is distinguishable from self-regulating systems whereupon the release
kinetics are controlled by the environmental conditions. The Generation 3 drug delivery
system actually controls the environmental conditions and seeks to achieve homeostasis,
that is, it targets achievement of a particular activity of the actuating biological specie
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within the environment that had elicited the release response in the first place. This
requires the implementation of feedback control.
The information flow from sensing to response in Generation 2 bioresponsive
hydrogels often involves dynamical concomitant perturbations such as chemical
reactions[238] or binding events

[239]

; diffusive, convective and/or migratory transport of

species [240, 241]; mechanical deformation [242]; and optical density changes [243]. Due to the
high interdependency of such changes within bioresponsive hydrogels, explicit solutions
derived from constitutive mathematical relations are invariably difficult and more often
unresolved. Thus, the approach to engineering and optimization of bioresponsive
hydrogels is commonly in vitro or in vivo experimentation coupled with mathematical
simplifications for analysis. This approach, while effective, can be time intensive and
may result in suboptimal systems. Fortunately, the exponential increase in computational
power over past decades is enabling numerical resolutions to constitutive relations, which
were previously inaccessible[244]. The coupling of Finite Element Modeling (FEM) with
bioresponsive hydrogels to investigate previously difficult or inaccessible relations has
and will continue to be a robust and fruitful area of research

[245-247]

. The complexity of

the models has scaled in parallel to increasing transistor density and has offered insights
into these systems. Initially, due to limited computational power, only uni-physical
models were explored, such anisotropic drug transport in complex geometries

[248, 249]

.

However, complete multiphysics models are currently being developed in silico to inform
the engineering of bioresponsive hydrogels [250].
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To this point, an in silico model of enzymatically mediated release from a
bioresponsive hydrogel was developed and is presented. The three-step process of release
occurs by (1) diffusion of an enzyme to and into a hydrogel matrix, (2) enzymatic
cleavage of a tethered peptide-prodrug conjugate that is a substrate specific to the
transported enzyme and (3) subsequent diffusive release of the active drug into the local
environment. In vitro variations of enzyme mediated release include the use of pendent or
polymer-backbone integrated substrates
matrix

[253, 254]

[251, 252]

, degradation or gelation of the hydrogel

and dynamic swelling or collapsing of the hydrogel matrix

[255, 256]

. This

work explores a nondegradable bioresponsive hydrogel with a pendant peptide substrateprodrug which when cleaved, activates and releases an active drug. The model was
validated by direct comparison of its results with previously published in vitro results
achieved for the release of a model chromophore, para-nitroaniline, by the enzyme
chymotrypsin [237].
Furthermore, the utility of the model was demonstrated by the design and
optimization of a drug delivery platform that focuses on achieving stasis in the biological
activity of the external enzyme that is inhibited by the released active drug. This platform
requires the implementation of, in addition to the above three steps, closed-loop feedback
coupling the release of the drug to the activity of the sense enzyme. The foregoing is a
requirement for Generation 3 classification. The particular implementation was
parameterized for the release of a competitive protease inhibitor, MAG283, via cleavage
of Acetyl-Pro-Leu-Gly|Leu-MAG-283 by MMP-9 in order to achieve targeted
homeostasis of MMP-9 activity via closed-loop feedback control. This is relevant for the
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pathophysiology of chronic wounds where normal metabolic activity has been elevated to
levels incompatible with acute wound healing. It is estimated that 1-2% of the population
will suffer from a chronic wound in their lifetime

[257]

. In 2009 it was estimated that

chronic wounds affect 6.5 million patients and the annual treatment cost is estimated to
be $25 billion.

Compounding the impact on society are disabilities, such as limb

amputation and loss of wages estimated at $39 billion, that result from the inability to
quickly and appropriately treat the disease to mitigate these problems

[258]

.

The

developed model identified key engineering parameters for the delivery platform, which
could address a chronic wound environment. Homeostatic drug delivery, where the focus
is no longer just using drug release rate to achieve targeted control of biochemical
activity within a biochemical pathway, represents a new paradigm in controlled drug
delivery and may be called Generation 3 Drug Delivery Devices [198].
3.2.

Methods

3.2.1. Modelling Approach and Setup
The in silico model was designed to match the physical, chemical and reactive
properties of a previously synthesized in vitro bioresponsive hydrogel [237]. Briefly, the in
vitro hydrogel system was comprised of a 2-hydroxyethyl methacrylate (HEMA) based
hydrogel. Transport properties of the polymer matrix were altered by changing the mol %
of the crosslinker tetraethyleneglycol diacrylate (TEGDA) which dictated the degree of
hydration, void fraction and tortuosity of the hydrogel. The chromogen (peptidechromophore conjugate) N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide (AAPFpNa) was
covalently attached to the polymer matrix by an amide bond formed using the coupling
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reagents, 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) and Nhydroxysulfosuccinimide sodium salt (Sulfo-NHS). Upon exposure to the enzyme,
chymotrypsin, the peptide was cleaved and the chromophore, p-nitroaniline, was
activated and released into the bathing solution wherein its concentration was measured
using UV-Vis spectroscopy (λ= 380nm, α = 10,430 M-1cm-1).
In silico modeling was performed using COMSOL Multiphysics 4.2a software
and data analysis was performed within MS Excel 2010 and Matlab R2012a. The model
was designed such that a hydrogel disk was immersed in a bathing solution of enzyme at
time, t0. The enzyme then diffused into the hydrogel matrix wherein an enzymatic
reaction (cleavage of the tethered peptide-chromogen conjugate) modeled by Michaelis–
Menten kinetics occurred and the activated chromophore then diffuses out into the
bathing solution, Figure 3-1. Parameters for the model were made dependent on the

Figure 3-1: Three step process of enzymatically releasing a chromophore from a
bioresponsive hydrogel. (Left) Diffusion of enzyme from solution into hydrogel matrix.
(Middle) Cleavage of chromophore–peptide bond to activate and release chromophore.
(Right) Diffusion of chromophore out of hydrogel matrix.
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mol% of crosslinker and these were determined experimentally or through theoretical
relations, Table 3-1.
Table 3-1: Parameters used in the in silico simulation of enzyme mediated drug release.
Parameter
%TEGDA
++

1%

5%

Value
7%

9%

12%

%

Units

12.07

12.07

12.07

12.07

12.07

nmol

71.01

134.72

163.85

180.15

160.55

uM

Mol percent TEGDA

0.02

0.02

0.02

0.02

0.02

mM

++

0.81

0.65

0.61

0.58

0.58

(cm)

++

0.33

0.25

0.23

0.23

0.26

(cm)

5.59
*
†
†

++

0.887

0.440

0.256

0.140

Description
Initial amount of chromogen in
hydrogel
Initial concentration of
chromogen in hydrogel
Initial concentration of enzyme
in solution
Diameter of hydrogel disk
Height of disk

-8

2 -1

Effective diffusivity of enzyme

-8

2 -1

×10 (cm s )

30.9

4.90

2.43

1.41

0.774

×10 (cm s )

3.55

3.55

3.55

3.55

3.55

s-1

Effective diffusivity of
chromophore
rate constant for MichaelisMenton rate equation

0.75

0.75

0.75

0.75

0.75

mM

Michaelis-Menton constant

23.3
138.1
2
1
0.78

23.3

23.3

23.3

23.3

kDa

Molecular Weight of Enzyme

138.12

138.12

138.12

138.12

Da

Molecular Weight of
chromophore

1
0.69

1
0.58

1
0.52

1
0.38

cm3
-

Solution volume
Void fraction of hydrogel

*Calculated using Stokes-Einstein relation
†Experimentally determined using methods described in [237]
++
From previous work [237]

The hydrogel was modeled as a static, non-swelling, porous scaffold which
followed from the assumptions that (1) the polymer is not temperature or pH sensitive,
(2) the hydrogel was non-degradable and (3) any chemical changes to the hydrogel
matrix due to peptide cleavage has negligible influence on hydrogel swelling as the
concentrations of the immobilized peptide conjugates are much smaller than the
concentrations of the pendant groups of the polymer. It should be noted that all previous
experimental data was gathered under constant physiological-like conditions, T = 37oC,
pH = 7.4.
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3.2.2. Model Validation and Sensitivity Analysis
Negation of mesh size effects on the model was verified by comparing the
solution concentration of the chromophore at t∞ to the theoretically expected value when
all chromogen has been converted to chromophore, Equations (44). Error from the
theoretical value was calculated by Equation (45).
(
|
Where

)

|

(44)
(45)

is the initial concentration of the chromogen in the gel,
is the final concentration of the chromophore in the solution and

and

are the volumes of the gel and solution, respectively. Increasing the number of
elements to approximately 104 was found to sufficiently reduce model error from
numerical approximations for all cross-linked densities, see Appendix‒B, Figure‒1.
Additionally, decreasing mesh sizing around the hydrogel-solution interface efficiently
improved the model performance as the interface region included large gradients that
contributed to overshooting.
A sensitivity analysis was performed to determine which reaction-transport
parameters had the greatest effect on the hydrogel release performance. The values of
Deff,enzyme, Deff,chromophore, KM and kcat were systematically altered to one order of magnitude
above and below their original values by taking twenty monotonically spaced values of
each parameter between the maximum (original value×101) and minimum (original
value×10-1). Sensitivity was measured by comparing the sum of the squared differences,
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SoS, in the release profile for a step change, n, in the parameter, Equation (46), results
shown in Appendix‒B, Figure‒2.
∑
Where

(46)

is the squared difference in the release profile n and release profile n+1 at

time t.
3.2.3. Investigation of Diffusion-Reaction Effects Through Transport Modeling
Three approaches were taken to investigate the modeling of the enzymatically
mediated release of the chromophore. First, a pure transport model was investigated
which only took into account diffusion of the enzyme into the hydrogel matrix
subsequently neglecting reaction effects. For mathematical simplicity, a monolithic
solution model for diffusion in the radial direction was used, Equation (47). It assumes a
homogenously distributed chromogen within the releasing material that is below its
solubility limit

[231]

. The validity of this model is based on the hypothesis that the

diffusion of the enzyme into the hydrogel is the rate-limiting step and consequently is the
primary phenomena regulating the release. Equation (47) was fit to release profiles by
varying Deff,enzyme to maximize the coefficient of determination, r2.
⁄

(
Where

and

)

(47)

are the cumulative amount of drug released at time t and ∞,

respectively, and R is the radius of the cylinder.
The second model, based on the Thiele modulus, Equations (48) ‒ (50), is a
diffusion-reaction model, which accounts for enzyme diffusion and coupled reaction
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kinetics [106]. This model neglects the diffusion of the chromophore by assuming it occurs
quickly relative to the other processes. Additionally, it approximates the enzyme catalytic
reaction as a first order reaction with the reaction specific rate constant,

.

(48)
( )(

[

(

)

)

(49)

]

(50)

Where η is the effectiveness factor, rapparent is the experimentally measured rate, rintrinsic is
the rate of reaction of the enzyme in bulk solution of substrate, φ is the Thiele modulus,
and α is geometrically dependent constant (α(slab) = 1, α(cylinder) = 2, α(sphere) = 3).
The effective diffusivities were determined previously from the Thiele modulus.
Finally, through numerical approximation, a diffusion-reaction-diffusion model
that accounts for enzyme diffusion, Michaelis-Menten type kinetics and chromophore
diffusion, was used to fit the release data. A nonlinear least squares (NLLS) method was
used to provide an iterative approach to converge on appropriate value of Deff,enzyme for the
model. A value of Deff,enzyme was first guessed, and then the in silico simulation was run
and an r2 value calculated. A new value of Deff,enzyme was then estimated using a NewtonRaphson approach to converge on a Deff,enzyme value which maximized r2.
3.2.4. Model Extension to Homeostatic Drug Delivery
After validation of the previously developed model, its utility was extended by
developing and optimizing an in silico drug delivery platform which could be used to
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achieve normal homeostatic conditions in chronic wounds that could lead to wound
closure. The pathology of chronic wounds is rooted in increased activity of matrix
metalloproteinases (MMPs), enzymes responsible for simultaneous degradation and
reconstruction of the extracellular matrix (ECM), resulting in the inability to reestablish
the ECM support for cellular proliferation

[259, 260]

. Specifically, elevated levels of MMP-

9 have been found in chronic wounds, and it is hypothesized that attenuation of the
enzyme activity to normal metabolic levels should lead to acute wound healing

[261-263]

.

To this end, an in silico bioresponsive hydrogel was simulated which released an MMP-9
inhibitor, MAG-283, from an immobilized MMP-9 peptide-inhibitor conjugate, AcetylPro-Leu-Gly|Leu-MAG-283 (PLG|L-MAG283), to result in attenuation of MMP-9
activity in the local bathing environment.

Figure 3-2: 2-dimenional representation of simulation setup for homeostatic drug
delivery using MMP-9 peptide-inhibitor conjugate to effect chronic wound environments.
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The model used a spherical geometry for the hydrogel, as fabrication techniques
for nano- to micron-sized hydrogel spheres are readily available

[264-266]

. A single

hydrogel sphere, shown in blue in Figure 3-2, was placed inside an open boundary
system, which maintained a volume, Rboundary = f(Vsystem), of 100× the hydrogel volume to
approximate an infinite boundary. At the boundary, the concentration of the enzyme was
fixed to approximate a continuous flux of enzyme being eluted and generated from
surrounding cells. A close-packed configuration of hydrogel spheres was assumed, and a
second radius, Reff, was used to represent the maximum distance over which the enzyme
activity needed to be attenuated. All relative enzyme activities were determined at this
distance. This geometric configuration represents an idealized case; however, Jain et al.
have shown how sphere densities can be controlled in wound environments through
chemical immobilization techniques

[267]

. Additionally, the system may be simulated and

optimized for other geometric configurations. The extent of attenuation at Reff was
measured as a percentage by taking the ratio of the amount of free enzyme available for
reaction, [E] a, given by Equation (51) for competitive inhibition, to the total amount of
enzyme, [E] T.

(51)
The inhibitor used was MAG-283, which is a competitive inhibitor of MMP-9
with a KI value of 2.2 nM [268]. The kinetic parameters of the peptide-inhibitor conjugate
were

based

on

the

peptide,

Acetyl-Pro-Leu-Gly-Leu-(3-[2,4-dinitrophenyl]-L-

,2,3diaminopropionyl)-Ala-Arg-NH2, which has a KM and kcat value of 4.22 μM and 4.23
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s-1, respectively

[269]

. The solution diffusivity of the MAG-283 was estimated using the
[106]

Stokes-Einstein relation, Equations (52) ‒ (54)

. Using the porous media model,

Equation (55), in conjugation with the Stokes-Einstein relation and assuming the
reflection and partitioning coefficients to be equal for MAG-283 and p-Nitroaniline, the
effective diffusivity of MAG-283 inside the hydrogel matrix was calculated. The
determined values were 2.62×10-7 and 5.41×10-6 cm2s-1 for the hydrogel and solution,
respectively. The effective diffusivities of MMP-9, Deff,MMP-9, were estimated by relating
known effective diffusivities of the previous enzyme to their respective molecular
weights as described and was calculated to be 4.90×10-8 cm2s-1, for 1mol% TEGDA, and
4.90×10-7 cm2s-1, similar to literature values 6×10-7cm2s-1

[270]

, for the hydrogel and

solution, respectively.
(52)
⁄

(

)

(53)
⁄

(

)

(54)
(55)

Where Rg is the ideal gas constant, T is temperature in Kelvin, μ is the viscosity of the
solution, a is an estimate of the molecular radius, ρ is the density of the peptide or protein
which is assumed to be 1 g cm-3, MW is molecular weight, NA is Avogadro's number, KP
is the partition coefficient, KR is the reflection coefficient, ε is void fraction and τ is
tortuosity.
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3.3.

Results and Discussion

3.3.1. Model Sensitivity
Transport of enzymes through hydrogel matrices for biologically mediated release
is a dynamic process, which involves diffusion-reaction phenomena; additionally,
complexities may arise from protein fouling
or enzyme accessibility

[274]

[271, 272]

, alternation of reaction kinetics

[273]

,

. Here, an in silico model of biologically mediated release

from a hydrogel is simplified to account for diffusion and reaction phenomena only. The
effects on the system of three processes, diffusion of the enzyme into the hydrogel,
reaction and activation of the chromogen/chromophore and diffusion of the chromophore
out of the hydrogel, were investigated to determine which process and parameter(s) affect
the model the greatest. Figure 3-3 shows the resulting SoS as calculated by Equation (46)
as a function of TEGDA mole% and the normalized parameter. The values for Deff,enzyme,

Figure 3-3: SoS values as determined by Equation ( 3 ) for Deff,enzyme (Red),
Deff,chromophore (black), KM (green) and kcat (purple). Threshold value of for any value
below 0.01 was set for graphical purposes.
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Deff,chromophore, KM and kcat were normalized to the values in Table 3-1. Large values of
SoS indicate high sensitivity while small values indicate low sensitivity.
By independently varying the parameters Deff,enzyme, Deff,chromophore, kcat and KM by
one order of magnitude away from the experimentally or theoretically estimated values, it
was apparent that the model was most sensitive to the Deff,enzyme since the SoS value was
approximately an order of magnitude higher than of any of the other parameters at all
cross-link densities. Additionally, the model was least sensitive to Deff,chromophore and
moderately sensitive to kcat and KM. This validates the NLLS approach of fitting the
transport models by varying Deff,enzyme since orders of magnitude changes to the other
parameters was required in order to influence the model as much as were incremental
changes in Deff,enzyme. The high sensitivity to Deff,enzyme was an expected result as it was
previously determined that the diffusion of the enzyme into the hydrogel matrix was the
rate limiting step. While the high sensitivity for Deff,enzyme was expected, this attribute of
the system may change depending on the kinetic parameters and geometric scale.
3.3.2. Investigation of Diffusion-Reaction-Diffusion Effects Through Transport
Modeling
Three approaches were taken to investigate modeling of the enzymatically
mediated release: monolithic solution, Thiele Modulus and NLLS fit.

After

determination of Deff,enzyme for each approach, the values were implemented in the in silico
model and the results were compared to experimental results. The determined parameters
for Deff,enzyme and associated r2 value for all three methods are shown in Table 3-2, and in
vitro () and in silico(―) release profiles for each method is shown in Figure 3-4A-C.
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From Table 3-2 and Figure 3-4, it is apparent that the monolithic solution approach
performed poorly as negative r2 values indicate the mean of the data provides a better fit
than the proposed monolithic solution equation.

In enzyme-mediated release, only

accounting for diffusion of the enzyme into the matrix is not sufficiently robust to
accurately model such systems. The Thiele modulus approach exhibited a marked
improvement in the r2 values calculated for the goodness of fit for the in silico to the in
vitro profiles.
Table 3-2: Deff,enzyme as determined by different modeling approaches. r2 values reported
for goodness of fit between in silico release profile and experimental release profile.
Monolithic Solution
%TEGDA

Deff,enzyme
2 -1

8

r2

(cm s ×10 )

Thiele Modulus
Deff,enzyme
2 -1

8

Nonlinear Least Squared Fit
r2

(cm s ×10 )

Deff,enzyme
2 -1

8

r2

(cm s ×10 )

1%

250.11

-3.89

6.90

0.93

5.59

0.97

5%

41.53

-25.32

1.40

0.56

0.89

0.98

7%

30.42

-57.82

0.60

0.77

0.44

0.95

9%

14.88

-82.59

0.40

0.62

0.26

0.96

12%

8.79

-133.78

0.10

0.56

0.14

0.84

The increase in r2 can be attributed to the inclusion of reaction kinetics in addition to
enzyme diffusion in the model. It is of particular interest that the model performed
sufficiently well for approximating the reaction as first order rather than by MichaelisMenton kinetics. This suggests that [S] is sufficient small and subsequently may be
approximated as a first order reaction. Finally, the NLLS approach resulted in the best fit
of the in silico profiles to the in vitro profiles. This is expected as the approach seeks to
maximize r2 by varying Deff,enzyme. While it can be argued that any parameter in the model
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could have been changed to achieve this result, the sensitivity analysis showed that only
minimal changes to the value of Deff,enzyme were required to affect the profiles. Conversely,
if other parameters were varied from their experimentally or theoretically determined
values, orders of magnitude changes would have been required. Overall, the use of a
NLLS fit in conjugation with a sensitivity analysis proves to be the best approach for
modeling enzyme-mediated release; however, reasonable computation expense is
required for the finite element modeling. The value of this in silico model is that it
allows the exploration of a wide range of scientifically relevant parameters at very little
experimental expense. Here, the Thiele modulus approach has been compared to a full
multiphysics modeling approach, and it is shown that the Thiele modulus may be
adequate as a first approximation.
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Figure 3-4: Experimental release profiles (  , diamonds) and numerical solutions to
release profiles ( ─ , solid lines) resolved with Deff,enzyme calculated by (A) Monolithic
Solution, (B) Thiele modulus and (C) NLLS. 82

3.3.3. Homeostatic Drug Delivery Considerations for Chronic Wound Environment
Homeostasis is achieved through complex, regulated interdependent control
systems intrinsic to metabolic pathways within the body. When normal metabolic
function deteriorates, therapeutic drugs may be administered to restore homeostatic
conditions. To improve the efficacy of therapeutic drugs, it is desirable to deliver them
locally and in metabolically relevant rates and amounts through drug delivery systems
[198]

. With the advances in hydrogel delivery platforms, this may now be achievable

through bioresponsive hydrogels with closed-loop feedback control. The general process
of such a system will involve the three previously discussed steps for release, and a fourth
step, which is the inhibition or activation of the relevant enzyme and subsequent
reduction or up-regulation of its activity. The engineering of such a system is complex as
it involves a balance between the rate of catalysis, transport and inhibition. Therefore,
such a system was investigated in silico for possible application in the treatment of
chronic wounds where attenuation of enzyme activity through closed-loop control could
reestablish normal wound healing.
The effect of hydrogel radius, R, effective diffusivity of MMP-9, Deff,MMP-9 and
loading concentration of the peptide-inhibitor conjugation,

, were studied. These

parameters were chosen as they are easily manipulated through manufacturing processes
and represent the most amenable engineering control parameters. Additional parameters
that affect the system, are enzyme kinetic parameters kcat, KM and KI. While changing the
peptide or inhibitor used in the delivery system can alter the system’s response, the range
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Figure 3-5: Attenuation profiles of MMP-9 under closed-looped control as a function of
peptide-inhibitor conjugate concentrations (dark spheres representing low and
concentration and lighter spheres representing high concentration) and hydrogel radius.
of values for these parameters and the substitution of the peptide or inhibitor may be
undesirable in an in vivo application.
It was demonstrated that under closed-loop control, local MMP-9 activity could
be reduced and maintained at a pseudo-steady state level (PSS) achieving homeostatis.
To reach a PSS, a minimum amount of

was required, Figure 3-5. As the loading

concentration was increased, a PSS was achieved, and its persistence over time positively
correlates with loading concentration. By increasing

, the time to react all of the

species within the hydrogel was extended which extends the period of inhibitor release.
Additionally, it was found that the level of attenuation,

⁄

, negatively correlates

with hydrogel radius. As radius was increased, the volume in which the enzyme reaction
occurred increased. This results in a larger flux of inhibitor into the local environment,
further reducing the MMP-9 activity level.
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Figure 3-6: (A) Relative enzyme activity levels as a function of hydrogel radius and
enzyme effective diffusivity. (B) Temporal relative enzyme activity levels for feedback
control systems operating in reaction limited, transition, and diffusion limited domains
(C) Enzyme activity as a function of hydrogel radius and enzyme concentration. (D) Low
(Diurnal) and high frequency enzyme activity cycle and the modulated response of the
controlled enzyme activity as function of time.
While

and R are key design parameters, the system was under reaction

limited conditions; apparent from calculation of the Thiele modulus at initial conditions,
and transport parameters become increasingly important as R is increased. The relation
between R and Deff,MMP-9 was investigated further to show significant reductions in the
PSS relative enzyme activities that could have significant therapeutic applications, Figure
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3-6A. When R was small, PSS attenuation levels primarily depended on R and show
little dependence on Deff,MMP-9; however, as R was increased, the level of attenuation for
different values of Deff,MMP-9 diverge. This divergence in attenuation was due to increased
influence of transport phenomena with the effective diffusivities of 4.9×10-8 and 7.1×1010

9

corresponding to 1 and 12mol% TEGDA, respectively. When R was large and Deff,MMPwas small, the system became diffusion limited which reduced inhibitor release rates

consequently reducing the level of enzyme activity attenuation.
Phenomenological domains of operation can be understood by the use of Equation
(50) resulting in Figure 3-6C. Setting φ = 1, and keeping Vmax, KM and α constant, a
parabolic relation between the radius and the effective diffusivity constant is established;
wherein, the rates of transport and reaction are equal. Utilizing competitive inhibition as
a feedback control mechanism, the system is initially, t0, optimized but quickly moves
into the reaction limited domain as KM is altered to a higher value, KMapp, and the
reaction rate is reduced. As peptide-inhibitor conjugate near the surface is consumed, the
system experiences a transition domain where transport and reaction kinetics are
equivalent in magnitude. Finally as more conjugate is consumed, the system moves into
the diffusion limited domain as the enzyme must travel further into the in interior of the
sphere to consume unreacted peptide-inhibitor conjugate. Depending on the domain, the
relative enzyme activity can vary vastly, as shown in Figure 3-6C, where the effective
diffusivities correspond to 1, 5, 7, 9 and 12mol% TEGDA with smaller spheres
representing high mol% TEGDA and larger spheres representing low mol% TEGDA.
When selecting physical characteristics of a system to achieve a pseudo-steady state, the
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balanced domain should be avoided as the relative enzyme activity is broad ranging in
this domain. By tuning the effective diffusivity, through monomer composition, and/or
the transport path length (ie. radius), through fabrication methods, the dominant domain
can be selected. The reaction limited domain may be selected by choosing small radii
and high diffusivity constants (ie. low cross-linking), and conversely, the diffusion
limited domain may be selected by choosing large radii and low diffusivity constants (ie.
high cross-linking).
After the key control parameters, being radius and loading concentration, of a
closed-loop hydrogel delivery system were investigated, the system’s capacity to control
the local activity in a chronic wound environment was explored. In chronic wounds,
MMP-9 activity varies from patient to patient and can range from 1-185 ng/mL with a
normal level < 1 ng/mL [275]. To restore normal MMP-9 activity, it is required that MMP9 activity be reduced independent of patient MMP-9 activity to an engineered set-point.
Attenuation levels were investigated for a range of MMP-9 activity from 1-200 ng/mL
and for various values of R, Figure 3-6B. The results demonstrate the importance of the
hydrogel radius. As R was increased, from 20 to 200 μm, the system was increasingly
able to reduce the local enzyme activity independent of the total enzyme concentration.
The hydrogel released a larger amount of inhibitor with increasing R thereby reducing the
PSS’s dependence on the local enzyme concentration. The final utility of this system is
demonstrated by Figure 3-6D.

The native enzyme activity is modeled under low

(diurnal) and high frequency cycling with a peak amplitude of 99.5ng/mL corresponding
to a MMP-9 activity of 1-200 ng/mL. While MMP-9 activity within a wound may vary
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over time, between wound types and/or patients, the engineered drug delivery system is
robust such that the modulated enzyme activity is constant and controlled to the desired
set point regardless of a dynamically changing environment. A spatial distribution of the
diurnal enzyme activity is provided in Appendix‒B, Figure‒3. This demonstrates an
advantage over sustained release formulations as they are unable to dynamically respond
to concentration cycles which may result from fluctuating cellular biochemistry.
Additionally, the system is designed to maximize the efficacy of the loaded drug as it
releases the drug “on demand” in response to spatiotemporal changes in MMP-9 activity
subsequently maintaining a targeted activity.

It should be noted that the in silico

simulation was performed for only one hydrogel sphere, and “cross-talk” between the
hydrogel microspheres may occur; however, qualitative effects will remain the same.
Increasing hydrogel radii and Deff will reduce activity and increasing loading
concentration for the same radius will increase operational lifetime. While this is true,
quantitative values, such as the amount of reduction of relative enzyme activity and the
value of operational lifetime may change. Changes will occur if the spheres are close
enough such that the released and diffusing inhibitor is able to inhibit the activity of the
enzyme within a neighboring microsphere.

Further enhancements to the in silico

simulations can be implemented to account for these effects.
3.4.

Conclusion
Bioresponsive hydrogels are being used more as their development results in new

functionalities and applications. As these polymeric materials proliferate, the
interdependencies between fundamental phenomena are continually being investigated to
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further the core science behind the performance of these polymers and to illuminate
engineering principles for their design. Here, the relation between reaction and diffusion
within a hydrogel matrix for enzyme mediated release applications has been investigated
in silico. It has been determined that the effective diffusivity is the key design parameter
for transport limited systems and that the Thiele modulus is a suitable method for
calculating this parameter when numerical techniques are not available. Additionally, the
utility of the model was demonstrated by investigating a drug delivery system aimed at
chronic wound environments where increased MMP-9 activity contributes to the disease
pathology

[275]

. It was shown that a hydrogel microsphere could be designed to achieve

homoeostatic conditions suitable for acute wound healing. Three key engineering
parameters were revealed: the effective diffusivity of MMP-9, the radius of the micro- to
nano-hydrogel microshere and the loading concentration of peptide-inhibitor conjugate.
The loading concentration (payload), in the reaction limited regime, determines how long
the sphere will release the drug and the loading has no effect on the resulting relative
enzyme activity. Conversely, the radius affects relative enzyme activity, Figure 6A.
Effective diffusivity has an effect on relative enzyme activity; however, it is negligible
for small radii spheres (<50μm) and for large spheres its effect begins to grow as
diffusive transport plays an increasingly larger role. Additional work to develop an in
vitro model will be to incorporate degradability into the system as pHEMA is a nonbiodegradable polymer. It was necessary to first work with a non-biodegradable system
in order to establish and validate the associated transport with reaction model.
Accordingly, p(HEMA) served only as a developmental platform for the investigation of
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the coupled diffusive transport with reaction kinetics. In the future, approaches will turn
to PEG-maleimide hydrogels with MMP-degradable crosslinks and MMP-degradable
pendant drug conjugates as described by Phelps and Garcia [189, 276]. In silico modeling of
bioresponsive hydrogels is an emerging trend in drug delivery systems. It will continue to
be a vital tool to glean insights into complex systems and serve as a method of
engineering and optimization into the indeterminate future.
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CHAPTER 4
2.

CONCLUSIONS AND FUTURE WORK

This work has investigated fundamental phenomena involved in ion release from
bioresponsive hydrogels and has shown that the key engineering parameters for design of
a closed-loop controlled drug delivery device can be determined and optimized through
finite element modeling.

Advances in drug delivery continue to produce lifesaving

technologies and this trend will continue as research into bioresponsive hydrogels
produce new insights into their operation and design. Continuation of the two veins of
research presented here, release of ionic species from zwitterionic hydrogels and the
investigation and design of a feedback controlled bioresponsive hydrogel, will produce
mechanistic understanding and design heuristics for future release constructs.
By continuing to study ion transport in hydrogels, the fundamental phenomena
involved in this system will allow for engineering and design of similar polymer
constructs amenable to controlled release of ionic species. Experimental work may focus
on the engineering of polymer pendent groups to control the polymer-ion complex
formed with divalent cations.
In this and previous work we have explored only a narrow range of PC content (1
and 5 mol%). A systematic study that investigates a range of MPC content [(1, 3, 5, 7, 9,
11, 50 and 100 mol% i.e. poly(MPC)] and that not only investigates ion release but also
elucidates the relative amount of free and bound water by (DSC), elucidates the structure
of any two–phase regions that may form e.g. the occurrence of micelle formation as a
function of composition (neutron scattering), studies ion transport using a two91

compartment cell in order to obtain the perm-selectivity of the individual ions for each
hydrogel and the use of electrical impedance spectroscopy to establish the conductivity of
each ion within the hydrogel will provide further insights.
In elucidating the temperature dependence of the transport coefficient, a feature
that is so important to possible insight into mechanism of transport, it will be necessary to
access a wider range of experimental temperatures. Where the use of ISEs may present
some limitation, the use of small aliquot sampling of the bathing space and atomic
absorption spectrometry can provide access to analysis of released concentrations at high
and low temperatures.
While phosphoryl choline is biomimetic, it is also zwitterionic and presents a
simultaneous mix of cationic and anionc sites, the molar distribution of which depends on
internal pH. To isolate the effect of a single internal anionic charge, this may be achieved
by systematically varying the mol % of 2-carboxylethyl acrylate (carboxylate anion –
weaker acid) or other ionic pendent group sodium methacryloyl propyl sulfonate
(sulfonate anion – stronger acid) to the prepolymer mixture. In this way, the role of a
fully ionized anionic species may be investigated. Conversely, the isolated effect of a
single internal cationic charge may be achieved by systematically varying the mol % of
2-aminoethyl methacrylate (ammonium cation) to the prepolymer mixture. In this way,
the role of a fully ionized cationic species may be investigated.
Additionally, designing temperature dependence of the system may allow for
actuated or controlled release via triggers from environmental cues. To confer
temperature dependence, any temperature responsive monomer may be included in the
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prepolymer mixture; among these are N-[tris(hydroxymethyl)methyl]-acrylamide
(HMMA) and sulfobetaine methacrylate (SBMA).

Additionally, the temperature

dependent effects of MPC may be further investigated by repeating work performed here
with higher MPC mol % hydrogels. This may allow for the tuning of the diffusional
exponent’s temperature dependence ultimately resulting in a hydrogels which controls
transport phenomena through temperature cues.

Further fundamental investigations

should involve elucidation of the phenomena contributing to the negative apparent
activation energy. This may proceed through studies using polymer swelling theory as
applied to temperature dependent and independent swelling hydrogels.

Others have

observed the volume phase transition temperature (VPTT) as a likely explanation for the
phenomena

[230]

.

Investigation and understanding of the temperature dependent

thermodynamic properties of MPC containing hydrogels will be necessary to elucidate
the relationship between polymer swelling and activation energies of transport. This may
proceed through temperature and ion concentration dependent swelling, AFM based
modulus measurements, TGA and use of non-crosslinked polymers in solution phase
transition determination.
Further work with feedback control loops for drug delivery using bioresponsive
hydrogels as the platform can eventually lead to the utilization of this technology in a
clinical setting, e.g. chronic wound healing. Before disease specific treatments using the
technology can be created, in vitro and in vivo demonstration of this system will be
required. In vitro research should be conducted to verify the results of the modeling work
presented here and include degradability as a characteristic of the hydrogel. The in vitro
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work may utilize a model enzyme system, such as Trypsin and Trypsin specific peptides
and inhibitors, or may utilize disease specific enzyme systems, such as MMPs. To
demonstrate the viability of a disease specific drug delivery system, diabetic mice, an
animal model used for chronic wounds

[277, 278]

, could be used in conjunction with a

disease specific MMP sensitive bioresponsive hydrogel. The microspheres could be place
in a hydrogel continuum that serves as a hydrogel wound dressing.
Research and engineering around bioresponsive hydrogels will continue to be a
fruitful field.

These materials have become integral parts of drug delivery, tissue

engineering and biosensing technologies and will continue to produce novel devices
which ultimately improve patient outcomes. The continued research and development of
bioresponsive hydrogels will guarantee further understanding of fundamental phenomena
guiding sense and respond characteristics as well as allow for design of devices
unmatched by current technologies.
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APPENDICES
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APPENDIX A
Chapter 2 Appendix

Appendix‒A Figure‒1: Calibration plots used to relate measure mV to [Ion] for
Calcium (A) and Potassium (B). Experimentally determined slopes as a function of
temperature for Calcium (C) and Potassium (D).
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Appendix A (Continued)

Appendix‒A Figure‒2: Predicted diffusion exponent as a function of aspect ratio for
cylinders. Where a is radius and l is cylinder thickness. Reprinted with permission
from [2].
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Appendix A (Continued)
Appendix‒A Table‒1: Nested ANOVA setup for statistical analysis of ion (Factor A)
and loading (Factor B) as main effects with Temperature as the nested variable for rate
constant, kKP, (Top) and diffusional exponent, n, (Bottom).
Factor B

kKP rate constant

Factor A

K+

Temp = 25

0.163

Temp = 31

0.385

Temp = 37

0.037

Temp = 45

0.190

Temp = 25

0.020
0.082

Temp = 31

0.058
0.020

Ca++
Temp = 37

0.105
0.040

Temp = 45

0.086
.040

0
0.308
0
0.077
0
0.100
0
0.115
0
0.028
0
0.088
0
0.094
0
0.167
0
0.065
0
0.087
0
0.055
0
0.077

0
0.151
0
0.134
0
0.133
0
0.094
0
0.024
0
0.076
0
0.016
0
0.021
0
0.065
0
0.160
0
0.076
0
0.020

Preloaded
0
0
0.163 0.130
0
0
0.100
0

0
0.077

0
0.095
0
0.098
0
0.019
0
0.063
0
0.050
0
0.118
0
0.073
0
0.075

0
0.151
0
0.025
0
0.086
0
0.145
0
0.032
0
0.113
0
0.065
0
0.054

0
0
0
0.079 0.169 0.231
0
0.148 0.084
0
0
0
0.048 0.180 0.158
0
0.104 0.084
0
0
0
0.147 0.087 0.145
0
0
0.096
0
0
0
0.037 0.035 0.055
0
0
0.040
0
0
0
0.087 0.135 0.076
0
0
0.069
0
0
0
0.007 0.061 0.036
0
0
0.012
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0
0.294
0
0.084
0
0.093
0
0.168
0
0.065

Postloaded
0
0
0.167 0.287
0
0
0.182 0.096
0
0
0.123 0.193
0
0
0.183 0.096
0
0
0.020 0.020

0
0.114
0
0.144
0
0.170
0
0.067
0
0.082

0

0
0
0
0
0.011 0.029 0.024 0.052

0

0
0
0
0
0.173 0.020 0.022 0.035

0

0
0
0
0
0.025 0.003 0.033 0.011

0

0
0
0
0

Appendix A (Continued)
Factor B

n Exponent

K+

0.33

0.19

0.35

Temp = 31

0.11

0.55

0.39

Temp = 37

0.68

0.40

0.40

Temp = 45

0.30

0.41

0.45

1.00

0.90

1.27

0.59

0.46

0.42

0.53

0.48

0.67

0.46

0.81

0.61

0.80

0.49

1.19

0.72

0.41

0.53

0.85

0.31

0.69

0.59

0.33

0.60

0.44

0.62

0.58

0.63

0.93

0.63

0.65

0.50

0.33

0.39

0.43

0.46

0.43

0.60

0.50

0.36

0.45

0.84

0.52

0.38

0.60

0.39

0.46

0.69

Temp = 31
Ca++
Temp = 37

Temp = 45

0.33

Postloaded

Temp = 25

Temp = 25

Factor A

Preloaded

0.42

0.38

0.45
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0.49

0.54

0.29

0.25

0.19

0.44

0.19

0.44

0.28

0.42

0.43

0.27

0.41

0.30

0.30

0.27

0.42

0.35

0.36

0.32

0.35

0.38

0.26

0.24

0.38

0.42

0.51

0.60

0.42

1.45

0.86

0.55

0.74

1.06

1.03

1.02

0.68

0.93

0.66

0.59

0.38

1.02

1.12

1.64

0.82

0.64

0.64

1.09

0.71

1.32

APPENDIX B
Chapter 3 Appendix

Appendix‒B Figure‒1: Error in theoretical value of release concentration as a
function of in silico elements. (Inset) Increased meshing around gel-solution interface
helped to increase accuracy which reducing computation expense.
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Appendix B (Continued)

Appendix‒B Figure‒2: Graphically demonstrated method for calculating the Sum of
Squared, SoS.

Appendix‒B Figure‒3: Spatial MMP-9 activity which is undergoing a diurnal cycle
around a hydrogel sphere without (top) and with (bottom) inhibitory feedback control.
The target MMP-9 activity for acute wound healing is <1 ng/mL.
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